background	background	NN	B-NP
glycosaminoglycan	glycosaminoglycan	NN	I-NP
(	(	-LRB-	0
glycosaminoglycan	glycosaminoglycan	NN	B-NP
)	)	-RRB-	0
are	are	VBP	0
negatively	negatively	RB	0
charged	charged	VBN	0
polysaccharides	polysaccharides	RB	0
derived	derived	VBN	0
from	from	IN	0
an	an	DT	0
amino	amino	JJ	0
hexose	hexose	NN	B-NP
.	.	.	0
They	They	PRP	0
are	are	VBP	0
structural	structural	JJ	0
and	and	CC	0
extracellular	extracellular	JJ	B-NP
matrix	matrix	NN	I-NP
functional	functional	JJ	I-NP
modulator	modulator	NN	I-NP
that	that	WDT	0
play	play	VBP	0
important	important	JJ	0
roles	roles	NNS	0
in	in	IN	0
CNS	CNS	NNP	B-NP
development	development	NN	0
and	and	CC	0
repair	repair	NN	0
.	.	.	0
They	They	PRP	0
exhibit	exhibit	VBD	0
both	both	DT	0
stimulatory	stimulatory	NN	B-NP
and	and	CC	0
inhibitory	inhibitory	JJ	B-NP
influence	influence	NN	I-NP
on	on	IN	0
neurite	neurite	JJ	B-NP
outgrowth	outgrowth	NN	I-NP
and	and	CC	0
survival	survival	NN	0
.	.	.	0
Evidence	Evidence	NN	0
demonstrates	demonstrates	VBZ	0
the	the	DT	0
heparin	heparin	JJ	B-NP
sulfate	sulfate	NN	I-NP
ability	ability	NN	I-NP
(	(	-LRB-	0
h	h	NN	B-NP
)	)	-RRB-	0
to	to	TO	0
bind	bind	VB	0
to	to	TO	0
growth/trophic	growth/trophic	NN	B-NP
factor	factor	NN	I-NP
and	and	CC	0
selectively	selectively	RB	0
regulate	regulate	VB	0
such	such	JJ	0
factors	factors	NNS	0
'	'	POS	0
receptor	receptor	NN	B-NP
[	[	-LRB-	0
1	1	CD	0
2	2	CD	0
]	]	-RRB-	0
.	.	.	0
They	They	PRP	0
can	can	MD	0
act	act	VB	0
as	as	IN	0
growth/trophic	growth/trophic	NN	B-NP
co-receptor	co-receptor	NN	I-NP
and	and	CC	0
survival	survival	NN	B-NP
factor	factor	NN	I-NP
to	to	TO	0
regulate	regulate	VB	0
cell	cell	NN	0
behavior	behavior	NN	0
and	and	CC	0
/	/	NNP	0
or	or	CC	0
restrict	restrict	VB	0
diffusion	diffusion	NNS	0
and	and	CC	0
create	create	VB	0
a	a	DT	0
relatively	relatively	RB	0
high	high	JJ	0
local	local	JJ	0
ligand	ligand	NN	B-NP
concentration	concentration	NN	I-NP
.	.	.	0
Pigment	Pigment	JJ	B-NP
epithelium-derived	epithelium-derived	JJ	I-NP
factor	factor	NN	I-NP
(	(	-LRB-	0
pigment	pigment	NN	B-NP
epithelium	epithelium	NN	I-NP
derived	derived	VBN	I-NP
factor	factor	NN	I-NP
)	)	-RRB-	0
is	is	VBZ	0
an	an	DT	0
extracellular	extracellular	JJ	B-NP
neuronal	neuronal	JJ	I-NP
differentiation	differentiation	NN	I-NP
and	and	CC	0
survival	survival	NN	B-NP
factor	factor	NN	I-NP
for	for	IN	0
cells	cells	NNS	0
derived	derived	VBN	0
from	from	IN	0
the	the	DT	0
retina	retina	NN	B-NP
and	and	CC	0
CNS	CNS	NNP	B-NP
.	.	.	0
It	It	PRP	0
induces	induces	VBZ	0
neuronal	neuronal	JJ	B-NP
differentiation	differentiation	NN	I-NP
in	in	IN	0
retinoblastoma	retinoblastoma	NN	B-NP
cell	cell	NN	I-NP
,	,	,	0
protects	protects	VBZ	0
retina	retina	JJ	B-NP
neuron	neuron	NN	I-NP
(	(	-LRB-	0
including	including	VBG	B-NP
photoreceptor	photoreceptor	NN	I-NP
)	)	-RRB-	0
from	from	IN	0
death	death	NN	0
by	by	IN	0
apoptosi	apoptosi	NN	B-NP
and	and	CC	0
other	other	JJ	0
insults	insults	NN	0
,	,	,	0
and	and	CC	0
has	has	VBZ	0
a	a	DT	0
morphogenetic	morphogenetic	JJ	B-NP
effect	effect	NN	I-NP
on	on	IN	0
photoreceptor	photoreceptor	JJ	B-NP
cell	cell	NN	I-NP
[	[	-LRB-	0
3	3	CD	0
4	4	CD	0
5	5	CD	0
6	6	CD	0
]	]	-RRB-	0
.	.	.	0
It	It	PRP	0
also	also	RB	0
has	has	VBZ	0
neurotrophic	neurotrophic	JJ	B-NP
effect	effect	NN	I-NP
on	on	IN	0
neuron	neuron	NN	B-NP
from	from	IN	0
the	the	DT	0
cerebellum	cerebellum	NN	B-NP
,	,	,	0
hippocampus	hippocampus	NN	B-NP
and	and	CC	0
spinal	spinal	JJ	B-NP
cord	cord	NN	I-NP
[	[	-LRB-	0
7	7	CD	0
8	8	CD	0
9	9	CD	0
10	10	CD	0
11	11	CD	0
12	12	CD	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
the	the	DT	0
intact	intact	JJ	0
retina	retina	NN	B-NP
,	,	,	0
this	this	DT	0
factor	factor	NN	B-NP
is	is	VBZ	0
identified	identified	VBN	0
as	as	IN	0
a	a	DT	0
secreted	secreted	JJ	0
protein	protein	NN	B-NP
associated	associated	VBN	0
by	by	IN	0
ionic	ionic	JJ	B-NP
interaction	interaction	NN	I-NP
with	with	IN	0
the	the	DT	0
interphotoreceptor	interphotoreceptor	JJ	B-NP
matrix	matrix	NN	I-NP
[	[	-LRB-	0
13	13	CD	0
14	14	CD	0
]	]	-RRB-	0
,	,	,	0
where	where	WRB	0
GAGs	GAGs	NNS	0
are	are	VBP	0
the	the	DT	0
major	major	JJ	0
polyanionic	polyanionic	JJ	B-NP
component	component	JJ	I-NP
.	.	.	0
Biochemically	Biochemically	NNP	0
,	,	,	0
pigment	pigment	NN	B-NP
epithelium	epithelium	NN	I-NP
derived	derived	VBN	I-NP
factor	factor	NN	I-NP
is	is	VBZ	0
a	a	DT	0
50-kDa	50-kDa	JJ	0
glycoprotein	glycoprotein	NN	0
with	with	IN	0
structural	structural	JJ	B-NP
homology	homology	NN	I-NP
to	to	TO	0
members	members	NNS	0
of	of	IN	0
the	the	DT	0
serine-protease	serine-protease	JJ	B-NP
inhibitor	inhibitor	NN	I-NP
(	(	-LRB-	0
serpin	serpin	LS	B-NP
)	)	-RRB-	0
superfamily	superfamily	NNS	0
[	[	-LRB-	0
3	3	CD	0
15	15	CD	0
]	]	-RRB-	0
.	.	.	0
However	However	RB	0
,	,	,	0
it	it	PRP	0
has	has	VBZ	0
no	no	DT	0
inhibitory	inhibitory	JJ	B-NP
effect	effect	NN	I-NP
on	on	IN	0
protea	protea	NN	B-NP
.	.	.	0
Its	Its	PRP$	0
neurotrophic	neurotrophic	JJ	B-NP
activity	activity	NN	I-NP
are	are	VBP	0
independent	independent	JJ	0
of	of	IN	0
its	its	PRP$	0
protease	protease	JJ	B-NP
inhibition	inhibition	JJ	I-NP
potential	potential	NN	I-NP
but	but	CC	0
dependent	dependent	JJ	0
on	on	IN	0
its	its	PRP$	0
interaction	interaction	NN	0
with	with	IN	0
cell-surface	cell-surface	JJ	B-NP
receptor	receptor	NN	I-NP
[	[	-LRB-	0
9	9	CD	0
12	12	CD	0
16	16	CD	0
17	17	CD	0
18	18	CD	0
]	]	-RRB-	0
.	.	.	0
pigment	pigment	NN	B-NP
epithelium	epithelium	NN	I-NP
derived	derived	VBN	I-NP
factor	factor	NN	I-NP
has	has	VBZ	0
high	high	JJ	0
binding	binding	JJ	0
cell-surface	cell-surface	JJ	B-NP
receptor	receptor	NN	I-NP
affinity	affinity	NN	I-NP
in	in	IN	0
human	human	JJ	0
retinoblastoma	retinoblastoma	NN	B-NP
y-79	y-79	NN	I-NP
cell	cell	NN	I-NP
(	(	-LRB-	0
K	K	NNP	0
d	d	SYM	0
=	=	SYM	0
2.7	2.7	CD	0
nM	nM	NN	B-NP
)	)	-RRB-	0
,	,	,	0
which	which	WDT	0
is	is	VBZ	0
mediated	mediated	VBN	0
by	by	IN	0
interaction	interaction	NN	B-NP
between	between	IN	0
a	a	DT	0
region	region	NN	0
spanning	spanning	VBG	0
amino	amino	JJ	0
acid	acid	NN	B-NP
position	position	NN	I-NP
78-121	78-121	VBP	0
of	of	IN	0
the	the	DT	0
PEDF	PEDF	NNP	B-NP
polypeptide	polypeptide	NN	I-NP
and	and	CC	0
the	the	DT	0
receptor	receptor	NN	B-NP
protein	protein	NN	I-NP
extracellular	extracellular	JJ	I-NP
domain	domain	NN	I-NP
[	[	-LRB-	0
18	18	CD	0
]	]	-RRB-	0
.	.	.	0
Blockage	Blockage	NNP	0
of	of	IN	0
these	these	DT	0
interaction	interaction	NN	B-NP
inhibits	inhibits	VBD	0
the	the	DT	0
pedf	pedf	NN	B-NP
neurotrophic	neurotrophic	NN	I-NP
effect	effect	NN	I-NP
.	.	.	0
pigment	pigment	NN	B-NP
epithelium	epithelium	NN	I-NP
derived	derived	VBN	I-NP
factor	factor	NN	I-NP
also	also	RB	0
has	has	VBZ	0
binding	binding	JJ	0
affinity	affinity	NN	B-NP
for	for	IN	0
GAGs	GAGs	NNP	0
,	,	,	0
such	such	JJ	0
as	as	RB	0
,	,	,	0
heparin	heparin	NN	B-NP
,	,	,	0
heparin-	heparin-	JJ	0
and	and	CC	0
chondroitin-sulfate	chondroitin-sulfate	NN	B-NP
,	,	,	0
but	but	CC	0
this	this	DT	0
affinity	affinity	NN	B-NP
is	is	VBZ	0
~1000-fold	~1000-fold	RB	0
lower	lower	JJR	0
than	than	IN	0
for	for	IN	0
the	the	DT	0
receptor	receptor	NN	B-NP
(	(	-LRB-	0
e.g.	e.g.	NNP	0
,	,	,	0
K	K	NNP	0
d	d	SYM	0
4	4	CD	0
μM	μM	NN	0
for	for	IN	0
the	the	DT	0
heparin-PEDF	heparin-PEDF	JJ	0
interactions	interactions	NNS	0
)	)	-RRB-	0
[	[	-LRB-	0
14	14	CD	0
19	19	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
binding	binding	JJ	0
to	to	TO	0
GAGs	GAGs	NNP	0
is	is	VBZ	0
mediated	mediated	VBN	0
by	by	IN	0
ionic	ionic	JJ	B-NP
interaction	interaction	NN	I-NP
between	between	IN	0
an	an	DT	0
area	area	NN	0
clustered	clustered	VBN	0
with	with	IN	0
positively	positively	RB	0
charged	charged	VBN	0
lysines	lysines	VBN	0
of	of	IN	0
pigment	pigment	NN	B-NP
epithelium	epithelium	NN	I-NP
derived	derived	VBN	I-NP
factor	factor	NN	I-NP
and	and	CC	0
the	the	DT	0
negatively	negatively	RB	0
charged	charged	VBN	0
GAGs	GAGs	JJ	0
.	.	.	0
In	In	IN	0
the	the	DT	0
PEDF	PEDF	NNP	B-NP
spatial	spatial	JJ	I-NP
structure	structure	NN	I-NP
,	,	,	0
the	the	DT	0
putative	putative	JJ	B-NP
GAG	GAG	NNP	I-NP
binding	binding	JJ	0
domain	domain	NN	0
is	is	VBZ	0
distinct	distinct	VBN	0
from	from	IN	0
and	and	CC	0
non-overlapping	non-overlapping	JJ	B-NP
with	with	IN	0
the	the	DT	0
neurotrophic	neurotrophic	JJ	0
active	active	JJ	0
region	region	NN	0
[	[	-LRB-	0
14	14	CD	0
20	20	CD	0
]	]	-RRB-	0
.	.	.	0
Because	Because	IN	0
pigment	pigment	NN	B-NP
epithelium	epithelium	NN	I-NP
derived	derived	VBN	I-NP
factor	factor	NN	I-NP
coexists	coexists	NN	0
with	with	IN	0
GAGs	GAGs	JJ	0
in	in	IN	0
extracellular	extracellular	JJ	B-NP
matrix	matrix	NN	I-NP
and	and	CC	0
has	has	VBZ	0
binding	binding	JJ	0
affinity	affinity	NN	B-NP
for	for	IN	0
them	them	PRP	0
,	,	,	0
it	it	PRP	0
is	is	VBZ	0
of	of	IN	0
interest	interest	NN	0
to	to	TO	0
investigate	investigate	VB	0
the	the	DT	0
role	role	NN	0
of	of	IN	0
GAGs	GAGs	JJ	0
on	on	IN	0
PEDF	PEDF	NNP	B-NP
activity	activity	NN	I-NP
.	.	.	0
Given	Given	VBN	0
that	that	IN	0
binding	binding	VBG	0
to	to	TO	0
cell-surface	cell-surface	JJ	B-NP
receptor	receptor	NN	I-NP
is	is	VBZ	0
the	the	DT	0
first	first	JJ	0
step	step	NN	0
in	in	IN	0
the	the	DT	0
pigment	pigment	NN	B-NP
epithelium	epithelium	NN	I-NP
derived	derived	VBN	I-NP
factor	factor	NN	I-NP
biological	biological	JJ	I-NP
activity	activity	NN	I-NP
,	,	,	0
we	we	PRP	0
used	used	VBD	0
human	human	JJ	0
retinoblastoma	retinoblastoma	NN	B-NP
y-79	y-79	NN	I-NP
cell	cell	NN	I-NP
and	and	CC	0
their	their	PRP$	0
conditioned	conditioned	JJ	0
media	media	NNS	0
(	(	-LRB-	0
CM	CM	NNP	0
)	)	-RRB-	0
as	as	IN	0
sources	sources	NNS	0
of	of	IN	0
functional	functional	JJ	B-NP
pedf	pedf	NN	I-NP
receptor	receptor	NN	I-NP
and	and	CC	0
extracellular	extracellular	JJ	B-NP
matrix	matrix	JJ	I-NP
component	component	JJ	I-NP
,	,	,	0
respectively	respectively	RB	0
,	,	,	0
to	to	TO	0
examine	examine	VB	0
the	the	DT	0
GAG	GAG	NNP	0
content	content	NN	0
in	in	IN	0
CM	CM	NNP	0
and	and	CC	0
their	their	PRP$	0
effects	effects	NNS	0
on	on	IN	0
pedf	pedf	NN	B-NP
ligand-receptor	ligand-receptor	JJ	I-NP
interaction	interaction	NN	I-NP
.	.	.	0
The	The	DT	0
data	data	NNS	0
suggest	suggest	VBP	0
that	that	IN	0
heparan	heparan	JJ	B-NP
sulfate	sulfate	NN	I-NP
participates	participates	VBZ	0
in	in	IN	0
the	the	DT	0
formation	formation	NN	0
of	of	IN	0
a	a	DT	0
pigment	pigment	NN	B-NP
epithelium	epithelium	NN	I-NP
derived	derived	VBN	I-NP
factor	factor	NN	I-NP
binding	binding	JJ	0
complex	complex	NN	0
with	with	IN	0
its	its	PRP$	0
cell-surface	cell-surface	JJ	B-NP
receptor	receptor	NN	I-NP
,	,	,	0
and	and	CC	0
constitutes	constitutes	VBZ	0
a	a	DT	0
pedf-receptor	pedf-receptor	NN	B-NP
interaction	interaction	NN	I-NP
positive	positive	JJ	I-NP
modulator	modulator	NN	I-NP
.	.	.	0
Results	Results	NNS	0
Complex	Complex	JJ	B-NP
formation	formation	NN	I-NP
between	between	IN	0
pigment	pigment	NN	B-NP
epithelium	epithelium	NN	I-NP
derived	derived	VBN	I-NP
factor	factor	NN	I-NP
and	and	CC	0
component	component	NN	B-NP
in	in	IN	0
media	media	NNS	0
conditioned	conditioned	VBN	0
by	by	IN	0
retinoblastoma	retinoblastoma	NN	B-NP
cell	cell	NN	I-NP
To	To	TO	0
determine	determine	VB	0
whether	whether	IN	0
pigment	pigment	NN	B-NP
epithelium	epithelium	NN	I-NP
derived	derived	VBN	I-NP
factor	factor	NN	I-NP
interacts	interacts	NN	0
with	with	IN	0
component	component	NN	B-NP
in	in	IN	0
media	media	NNS	0
conditioned	conditioned	VBN	0
by	by	IN	0
retinoblastoma	retinoblastoma	NN	B-NP
cell	cell	NN	I-NP
(	(	-LRB-	0
CM	CM	NNP	0
)	)	-RRB-	0
,	,	,	0
we	we	PRP	0
used	used	VBD	0
an	an	DT	0
ultrafiltration	ultrafiltration	JJ	B-NP
assay	assay	NN	I-NP
.	.	.	0
In	In	IN	0
this	this	DT	0
assay	assay	NN	B-NP
,	,	,	0
soluble	soluble	JJ	0
pigment	pigment	NN	B-NP
epithelium	epithelium	NN	I-NP
derived	derived	VBN	I-NP
factor	factor	NN	I-NP
of	of	IN	0
50-kDa	50-kDa	NNP	0
is	is	VBZ	0
filtered	filtered	VBN	0
through	through	IN	0
a	a	DT	0
membrane	membrane	NN	0
with	with	IN	0
an	an	DT	0
mw	mw	NN	B-NP
exclusion	exclusion	NN	I-NP
limit	limit	NN	I-NP
100,000	100,000	CD	0
,	,	,	0
however	however	RB	0
it	it	PRP	0
is	is	VBZ	0
retained	retained	VBN	0
upon	upon	IN	0
formation	formation	NN	0
of	of	IN	0
a	a	DT	0
complex	complex	JJ	0
larger	larger	JJR	0
than	than	IN	0
this	this	DT	0
limit	limit	NN	0
[	[	-LRB-	0
14	14	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
binding	binding	JJ	0
reactions	reactions	NNS	0
were	were	VBD	0
with	with	IN	0
a	a	DT	0
given	given	VBN	0
125I-PEDF	125I-PEDF	CD	0
concentration	concentration	NN	0
and	and	CC	0
CM	CM	NNP	0
.	.	.	0
Incubations	Incubations	NNP	0
were	were	VBD	0
at	at	IN	0
4°C	4°C	CD	0
to	to	TO	0
minimize	minimize	VB	0
enzymatic	enzymatic	JJ	B-NP
degradation	degradation	NN	I-NP
of	of	IN	0
proteins	proteins	NNS	0
and	and	CC	0
glycosaminglycan	glycosaminglycan	NN	B-NP
during	during	IN	0
the	the	DT	0
reaction	reaction	NN	0
.	.	.	0
We	We	PRP	0
found	found	VBD	0
that	that	IN	0
22	22	CD	0
%	%	NN	0
of	of	IN	0
125I-PEDF	125I-PEDF	NNP	0
was	was	VBD	0
retained	retained	VBN	0
by	by	IN	0
the	the	DT	0
membrane	membrane	NN	0
in	in	IN	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
concentrated	concentrated	JJ	0
CM	CM	NNP	0
,	,	,	0
compared	compared	VBN	0
to	to	TO	0
only	only	RB	0
4	4	CD	0
%	%	NN	0
retention	retention	NN	0
in	in	IN	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
defined	defined	JJ	0
medium	medium	NN	0
(	(	-LRB-	0
non-conditioned	non-conditioned	JJ	B-NP
medium	medium	NN	I-NP
)	)	-RRB-	0
concentrated	concentrated	VBN	0
in	in	IN	0
an	an	DT	0
identical	identical	JJ	0
fashion	fashion	NN	0
.	.	.	0
Specific	Specific	JJ	B-NP
retention	retention	NN	I-NP
,	,	,	0
termed	termed	VBD	B-NP
PEDF	PEDF	NNP	I-NP
bound	bound	NN	I-NP
,	,	,	0
was	was	VBD	0
calculated	calculated	VBN	0
by	by	IN	0
subtracting	subtracting	VBG	0
the	the	DT	0
retention	retention	NN	0
in	in	IN	0
defined	defined	JJ	0
media	media	NNS	0
from	from	IN	0
that	that	DT	0
in	in	IN	0
CM	CM	NNP	0
.	.	.	0
Figure	Figure	NN	0
1shows	1shows	NN	0
that	that	IN	0
pigment	pigment	NN	B-NP
epithelium	epithelium	NN	I-NP
derived	derived	VBN	I-NP
factor	factor	NN	I-NP
was	was	VBD	0
specifically	specifically	RB	0
retained	retained	VBN	0
when	when	WRB	0
mixed	mixed	VBN	0
with	with	IN	0
soluble	soluble	JJ	0
conditioned	conditioned	JJ	0
media	media	NNS	0
and	and	CC	0
the	the	DT	0
value	value	NN	0
for	for	IN	0
PEDF	PEDF	NNP	B-NP
bound	bound	NN	I-NP
increased	increased	VBD	0
proportionally	proportionally	VBN	0
to	to	TO	0
the	the	DT	0
concentration	concentration	NN	B-NP
factor	factor	NN	I-NP
of	of	IN	0
the	the	DT	0
media	media	NNS	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
1A	1A	NNP	0
)	)	-RRB-	0
.	.	.	0
Interestingly	Interestingly	RB	0
,	,	,	0
protease	protease	JJ	B-NP
treatment	treatment	NN	I-NP
of	of	IN	0
the	the	DT	0
CM	CM	NNP	0
did	did	VBD	0
not	not	RB	0
abolish	abolish	VB	0
the	the	DT	0
binding	binding	NN	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
1B	1B	NNP	0
)	)	-RRB-	0
.	.	.	0
These	These	DT	0
observation	observation	NN	B-NP
revealed	revealed	VBD	0
that	that	IN	0
the	the	DT	0
retained	retained	JJ	0
forms	forms	NNS	0
in	in	IN	0
the	the	DT	0
CM	CM	NNP	0
were	were	VBD	0
pedf	pedf	NN	B-NP
complex	complex	JJ	I-NP
≥	≥	CD	0
100-kDa	100-kDa	CD	0
,	,	,	0
and	and	CC	0
that	that	IN	0
the	the	DT	0
majority	majority	NN	0
of	of	IN	0
these	these	DT	0
complexes	complexes	NNS	0
were	were	VBD	0
formed	formed	VBN	0
with	with	IN	0
soluble	soluble	JJ	0
CM	CM	NN	0
components	components	NNS	0
other	other	JJ	0
than	than	IN	0
proteins	proteins	NNS	0
.	.	.	0
Heparin	Heparin	NNP	B-NP
and	and	CC	0
heparan	heparan	NN	B-NP
sulfate	sulfate	NN	I-NP
in	in	IN	0
the	the	DT	0
conditioned	conditioned	JJ	0
media	media	NNS	0
with	with	IN	0
pedf	pedf	NN	B-NP
gag	gag	NN	I-NP
affinity	affinity	NN	I-NP
and	and	CC	0
polyanion	polyanion	NN	B-NP
in	in	IN	0
the	the	DT	0
CM	CM	NNP	0
were	were	VBD	0
fractionated	fractionated	VBN	0
by	by	IN	0
anion-exchange	anion-exchange	JJ	B-NP
column	column	NN	I-NP
chromatography	chromatography	VBZ	0
followed	followed	VBN	0
by	by	IN	0
PEDF-affinity	PEDF-affinity	JJ	B-NP
column	column	NN	I-NP
chromatography	chromatography	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	CD	0
2	2	CD	0
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
GAG	GAG	NNP	0
content	content	NN	0
was	was	VBD	0
followed	followed	VBN	0
by	by	IN	0
staining	staining	NN	0
with	with	IN	0
Toluidine	Toluidine	NNP	B-NP
Blue-O	Blue-O	NNP	I-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
2C	2C	NNP	0
,	,	,	0
2D	2D	NNP	0
,	,	,	0
2E	2E	CD	0
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
final	final	JJ	B-NP
fraction	fraction	NN	I-NP
(	(	-LRB-	0
CM	CM	NNP	0
pigment	pigment	NN	B-NP
epithelium	epithelium	NN	I-NP
derived	derived	VBN	I-NP
factor	factor	NN	I-NP
)	)	-RRB-	0
contained	contained	VBD	0
components	components	NNS	0
with	with	IN	0
binding	binding	JJ	0
pigment	pigment	NN	B-NP
epithelium	epithelium	NN	I-NP
derived	derived	VBN	I-NP
factor	factor	NN	I-NP
affinity	affinity	NN	I-NP
that	that	IN	0
stained	stained	NN	0
with	with	IN	0
Toluidine	Toluidine	NNP	B-NP
Blue-O	Blue-O	NNP	I-NP
and	and	CC	0
migrated	migrated	NN	0
as	as	IN	0
high	high	JJ	0
molecular	molecular	JJ	B-NP
weight	weight	NN	I-NP
gag	gag	NN	I-NP
.	.	.	0
To	To	TO	0
determine	determine	VB	0
the	the	DT	0
type	type	NN	0
of	of	IN	0
sulfated	sulfated	JJ	B-NP
GAG	GAG	NN	I-NP
in	in	IN	0
the	the	DT	0
media	media	NNS	0
,	,	,	0
we	we	PRP	0
designed	designed	VBD	0
a	a	DT	0
spectrophotometric	spectrophotometric	JJ	B-NP
assay	assay	NN	I-NP
using	using	VBG	0
heparinasa	heparinasa	NN	B-NP
and	and	CC	0
heparitinase	heparitinase	NN	B-NP
,	,	,	0
specific	specific	JJ	0
degrading	degrading	JJ	0
enzymes	enzymes	NN	0
for	for	IN	0
heparin	heparin	NN	B-NP
and	and	CC	0
heparan	heparan	NN	B-NP
sulfate	sulfate	NN	I-NP
,	,	,	0
respectively	respectively	RB	0
(	(	-LRB-	0
Fig.	Fig.	CD	0
3	3	CD	0
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
activities	activities	NNS	0
of	of	IN	0
both	both	DT	0
GAG	GAG	NNP	0
lyases	lyases	VBD	0
reached	reached	VBN	0
a	a	DT	0
plateau	plateau	NN	0
by	by	IN	0
one	one	CD	0
hour	hour	NN	0
of	of	IN	0
incubation	incubation	NNS	0
(	(	-LRB-	0
Figs.	Figs.	NNP	0
3A	3A	NNP	0
,	,	,	0
3C	3C	CD	0
)	)	-RRB-	0
and	and	CC	0
the	the	DT	0
degradation	degradation	NN	0
of	of	IN	0
GAG	GAG	NNP	0
substrates	substrates	NN	0
between	between	IN	0
0-30	0-30	CD	0
μg	μg	NN	B-NP
was	was	VBD	0
linear	linear	VBN	0
.	.	.	0
Both	Both	DT	0
CM	CM	NNP	0
and	and	CC	0
CM	CM	NNP	0
heparinase	heparinase	NN	B-NP
pedfcontained	pedfcontained	NN	I-NP
substrate	substrate	NN	I-NP
and	and	CC	0
heparitinasa	heparitinasa	NN	B-NP
(	(	-LRB-	0
Figs.	Figs.	NNP	0
3B	3B	NNP	0
,	,	,	0
3D	3D	CD	0
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
amount	amount	NN	0
of	of	IN	0
GAGs	GAGs	NNP	0
was	was	VBD	0
determined	determined	VBN	0
by	by	IN	0
comparison	comparison	NN	0
of	of	IN	0
the	the	DT	0
amount	amount	NN	0
of	of	IN	0
Δ	Δ	NNP	0
4-hexuronate	4-hexuronate	NNP	0
produced	produced	VBD	0
with	with	IN	0
CM	CM	NNP	0
samples	samples	NNS	0
to	to	TO	0
the	the	DT	0
standard	standard	JJ	0
curves	curves	NN	0
with	with	IN	0
commercial	commercial	JJ	B-NP
gag	gag	NN	I-NP
.	.	.	0
The	The	DT	0
estimated	estimated	JJ	0
content	content	NN	0
of	of	IN	0
GAGs	GAGs	JJ	0
in	in	IN	0
CM	CM	NNP	0
varied	varied	VBD	0
between	between	IN	0
12.4-22.7	12.4-22.7	CD	0
heparin	heparin	NN	B-NP
μg/ml	μg/ml	NN	I-NP
and	and	CC	0
between	between	IN	0
9-10	9-10	CD	0
hs-like	hs-like	NN	B-NP
molecule	molecule	NN	I-NP
μg/ml	μg/ml	NN	I-NP
,	,	,	0
among	among	IN	0
media	media	NNS	0
conditioned	conditioned	VBN	0
by	by	IN	0
three	three	CD	0
different	different	JJ	0
batches	batches	NNS	0
of	of	IN	0
y-79	y-79	NN	B-NP
cell	cell	NN	I-NP
.	.	.	0
The	The	DT	0
estimated	estimated	JJ	0
GAG	GAG	NNP	0
content	content	NN	0
in	in	IN	0
CM	CM	NNP	0
PEDFranged	PEDFranged	NN	B-NP
0.2-1.8	0.2-1.8	FW	0
μg	μg	NN	B-NP
/	/	NN	I-NP
μl	μl	NN	I-NP
and	and	CC	0
0.1-0.4	0.1-0.4	CD	0
heparin	heparin	NN	B-NP
μg/μl	μg/μl	NN	I-NP
and	and	CC	0
heparan	heparan	NN	B-NP
sulfate	sulfate	NN	I-NP
,	,	,	0
respectively	respectively	RB	0
.	.	.	0
Similar	Similar	JJ	0
assays	assays	NN	0
were	were	VBD	0
followed	followed	VBN	0
with	with	IN	0
chondroitinase	chondroitinase	JJ	B-NP
ABC	ABC	NNP	I-NP
,	,	,	0
but	but	CC	0
its	its	PRP$	0
substrates	substrates	NN	0
,	,	,	0
ΔDi4S	ΔDi4S	NNP	0
,	,	,	0
dermatan	dermatan	NN	B-NP
and	and	CC	0
ΔDi6S	ΔDi6S	NNP	0
,	,	,	0
in	in	IN	0
CM	CM	NNP	0
were	were	VBD	0
below	below	IN	0
detection	detection	JJ	B-NP
limit	limit	NN	I-NP
.	.	.	0
These	These	DT	0
results	results	NNS	0
demonstrated	demonstrated	VBN	0
that	that	IN	0
CM	CM	NNP	0
and	and	CC	0
CM	CM	NNP	0
PEDFcontained	PEDFcontained	NNP	0
heparin-	heparin-	NNP	B-NP
and	and	CC	0
hs-like	hs-like	NN	B-NP
molecule	molecule	NN	I-NP
,	,	,	0
demonstrating	demonstrating	VBG	0
that	that	IN	0
y-79	y-79	NN	B-NP
cell	cell	NN	I-NP
produced	produced	VBD	0
GAGs	GAGs	JJ	0
with	with	IN	0
binding	binding	JJ	0
pigment	pigment	NN	B-NP
epithelium	epithelium	NN	I-NP
derived	derived	VBN	I-NP
factor	factor	NN	I-NP
affinity	affinity	NN	I-NP
.	.	.	0
Media	Media	NNS	0
conditioned	conditioned	VBN	0
by	by	IN	0
retinoblastoma	retinoblastoma	NN	B-NP
cell	cell	NN	I-NP
enhances	enhances	VBZ	0
the	the	DT	0
125I-PEDF	125I-PEDF	JJ	0
binding	binding	NN	0
to	to	TO	0
cell-surface	cell-surface	JJ	B-NP
receptor	receptor	NN	I-NP
We	We	PRP	0
have	have	VBP	0
demonstrated	demonstrated	VBN	0
previously	previously	RB	0
that	that	IN	0
biologically	biologically	JJ	0
active	active	JJ	0
125I-PEDF	125I-PEDF	NN	0
binds	binds	VBZ	0
specifically	specifically	RB	0
,	,	,	0
competitively	competitively	RB	0
and	and	CC	0
with	with	IN	0
high	high	JJ	0
affinity	affinity	NN	B-NP
to	to	TO	0
y-79	y-79	NN	B-NP
cell	cell	NN	I-NP
cell-surface	cell-surface	JJ	I-NP
receptor	receptor	NN	I-NP
[	[	-LRB-	0
18	18	CD	0
]	]	-RRB-	0
.	.	.	0
Because	Because	IN	0
the	the	DT	0
reaction	reaction	NN	B-NP
condition	condition	NN	I-NP
were	were	VBD	0
identical	identical	JJ	0
to	to	TO	0
those	those	DT	0
used	used	VBN	0
for	for	IN	0
biological	biological	JJ	B-NP
assay	assay	NN	I-NP
,	,	,	0
the	the	DT	0
binding	binding	JJ	0
reactions	reactions	NNS	0
were	were	VBD	0
performed	performed	VBN	0
in	in	IN	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
media	media	NNS	0
conditioned	conditioned	VBN	0
by	by	IN	0
the	the	DT	0
cells	cells	NNS	0
for	for	IN	0
16	16	CD	0
hours	hours	NNS	0
(	(	-LRB-	0
CM	CM	NNP	0
)	)	-RRB-	0
.	.	.	0
We	We	PRP	0
investigated	investigated	VBD	0
the	the	DT	0
effect	effect	NN	0
of	of	IN	0
components	components	NNS	0
of	of	IN	0
the	the	DT	0
CM	CM	NNP	0
,	,	,	0
a	a	DT	0
source	source	NN	0
of	of	IN	0
extracellular	extracellular	JJ	B-NP
matrix	matrix	NN	I-NP
,	,	,	0
on	on	IN	0
the	the	DT	0
pedf-receptor	pedf-receptor	NN	B-NP
interaction	interaction	NN	I-NP
using	using	VBG	0
CM	CM	NNP	0
and	and	CC	0
non-conditioned	non-conditioned	JJ	B-NP
defined	defined	JJ	0
media	media	NNS	0
in	in	IN	0
radioligand	radioligand	JJ	B-NP
binding	binding	JJ	I-NP
assay	assay	NN	I-NP
.	.	.	0
Comparison	Comparison	NN	0
of	of	IN	0
reactions	reactions	NNS	0
in	in	IN	0
the	the	DT	0
absence	absence	NN	B-NP
and	and	CC	0
presence	presence	NN	0
of	of	IN	0
CM	CM	NNP	0
showed	showed	VBD	0
that	that	IN	0
the	the	DT	0
specific	specific	JJ	0
PEDF-binding	PEDF-binding	JJ	B-NP
to	to	TO	0
y-79	y-79	NN	B-NP
cell-surface	cell-surface	JJ	I-NP
receptor	receptor	NN	I-NP
was	was	VBD	0
6.8-fold	6.8-fold	CD	0
higher	higher	JJR	0
with	with	IN	0
conditioned	conditioned	JJ	0
medium	medium	NN	0
than	than	IN	0
with	with	IN	0
defined	defined	JJ	0
medium	medium	NN	0
(	(	-LRB-	0
Fig.	Fig.	CD	0
4	4	CD	0
)	)	-RRB-	0
.	.	.	0
Note	Note	NN	0
that	that	IN	0
with	with	IN	0
the	the	DT	0
binding	binding	JJ	0
method	method	NN	0
used	used	VBN	0
,	,	,	0
the	the	DT	0
amount	amount	NN	0
of	of	IN	0
125I-PEDF	125I-PEDF	NNP	0
retained	retained	VBD	0
in	in	IN	0
CM	CM	NNP	0
without	without	IN	0
cells	cells	NNS	0
is	is	VBZ	0
the	the	DT	0
same	same	JJ	0
to	to	TO	0
the	the	DT	0
amount	amount	NN	0
of	of	IN	0
non-specific	non-specific	JJ	0
125I-PEDF	125I-PEDF	CD	0
binding	binding	NNS	0
(	(	-LRB-	0
reactions	reactions	NNS	0
with	with	IN	0
cells	cells	NNS	0
and	and	CC	0
in	in	IN	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
50-fold	50-fold	CD	0
molar	molar	JJ	B-NP
excess	excess	NN	I-NP
of	of	IN	0
unlabeled	unlabeled	JJ	0
pigment	pigment	NN	B-NP
epithelium	epithelium	NN	I-NP
derived	derived	VBN	I-NP
factor	factor	NN	I-NP
)	)	-RRB-	0
[	[	-LRB-	0
18	18	CD	0
]	]	-RRB-	0
,	,	,	0
indicating	indicating	VBG	B-NP
retention	retention	NN	I-NP
by	by	IN	0
pedf-receptor	pedf-receptor	NN	B-NP
pei-treated	pei-treated	NN	I-NP
glass-fiber	glass-fiber	JJ	I-NP
filter	filter	NN	I-NP
or	or	CC	0
gag-pedf-receptor	gag-pedf-receptor	NN	B-NP
complex	complex	JJ	I-NP
rather	rather	RB	0
than	than	IN	0
PEDF-GAG	PEDF-GAG	JJ	B-NP
.	.	.	0
similar	similar	JJ	B-NP
result	result	NN	I-NP
were	were	VBD	0
obtained	obtained	VBN	0
when	when	WRB	0
the	the	DT	0
cell-bound	cell-bound	JJ	0
125I-PEDF	125I-PEDF	NN	0
was	was	VBD	0
separated	separated	VBN	0
by	by	IN	0
centrifugation	centrifugation	NN	B-NP
,	,	,	0
rather	rather	RB	0
than	than	IN	0
filtration	filtration	NN	0
through	through	IN	0
glass-fiber	glass-fiber	JJ	B-NP
filter	filter	NN	I-NP
,	,	,	0
and	and	CC	0
comparing	comparing	VBG	B-NP
reaction	reaction	NN	I-NP
with	with	IN	0
CM	CM	NNP	0
versus	versus	CC	0
those	those	DT	0
with	with	IN	0
1	1	CD	0
%	%	NN	0
BSA	BSA	NN	B-NP
in	in	IN	0
phosphate	phosphate	NN	B-NP
buffered	buffered	NN	I-NP
saline	saline	JJ	I-NP
(	(	-LRB-	0
data	data	NNS	0
not	not	RB	0
shown	shown	VBN	0
)	)	-RRB-	0
.	.	.	0
These	These	DT	0
observation	observation	NN	B-NP
showed	showed	VBD	0
that	that	IN	0
a	a	DT	0
component	component	NN	B-NP
(	(	-LRB-	I-NP
s	s	LS	I-NP
)	)	-RRB-	I-NP
secreted	secreted	NN	I-NP
by	by	IN	0
retinoblastoma	retinoblastoma	NN	B-NP
cell	cell	NN	I-NP
enhanced	enhanced	VBN	0
the	the	DT	0
pedf-receptor	pedf-receptor	NN	B-NP
interaction	interaction	NN	I-NP
.	.	.	0
Effect	Effect	NN	0
of	of	IN	0
gag	gag	NN	B-NP
lyas	lyas	NNP	I-NP
and	and	CC	0
chlorate	chlorate	NN	B-NP
on	on	IN	0
125I-PEDF	125I-PEDF	CD	0
binding	binding	NN	0
to	to	TO	0
cell-surface	cell-surface	JJ	B-NP
receptor	receptor	NN	I-NP
To	To	TO	0
deplete	deplete	VB	0
the	the	DT	0
heparan	heparan	NN	B-NP
sulfate	sulfate	NN	I-NP
y-79	y-79	NN	I-NP
cell	cell	NN	I-NP
culture	culture	NN	I-NP
and	and	CC	0
heparin-like	heparin-like	JJ	B-NP
gag	gag	NN	I-NP
,	,	,	0
we	we	PRP	0
used	used	VBD	0
heparitinase	heparitinase	JJ	0
and	and	CC	0
heparinase	heparinase	NN	B-NP
,	,	,	0
respectively	respectively	RB	0
.	.	.	0
The	The	DT	0
cultures	cultures	NNS	0
were	were	VBD	0
pretreated	pretreated	VBN	0
with	with	IN	0
each	each	DT	0
GAG	GAG	NNP	B-NP
lyase	lyase	NN	I-NP
before	before	IN	0
using	using	VBG	0
them	them	PRP	0
in	in	IN	0
radioligand	radioligand	JJ	B-NP
binding	binding	JJ	I-NP
assay	assay	NN	I-NP
.	.	.	0
The	The	DT	0
morphology	morphology	NN	0
and	and	CC	0
viability	viability	NN	0
of	of	IN	0
the	the	DT	0
cells	cells	NNS	0
were	were	VBD	0
not	not	RB	0
affected	affected	VBN	0
with	with	IN	0
the	the	DT	0
gag	gag	NN	B-NP
lyase	lyase	NN	I-NP
treatment	treatment	NN	I-NP
.	.	.	0
Figure	Figure	NN	0
5Ashows	5Ashows	NN	0
that	that	IN	0
specific	specific	JJ	0
125I-PEDF	125I-PEDF	CD	0
binding	binding	NNS	0
decreased	decreased	VBD	0
significantly	significantly	RB	0
in	in	IN	0
heparitinase	heparitinase	JJ	B-NP
treated	treated	JJ	I-NP
culture	culture	NN	I-NP
compared	compared	VBN	0
to	to	TO	0
untreated	untreated	VB	0
controls	controls	NNS	0
,	,	,	0
and	and	CC	0
less	less	RBR	0
drastically	drastically	RB	0
in	in	IN	0
heparinase	heparinase	JJ	B-NP
treated	treated	JJ	I-NP
one	one	CD	I-NP
.	.	.	0
Hyaluronidase	Hyaluronidase	JJ	B-NP
treatment	treatment	NN	I-NP
to	to	TO	0
deplete	deplete	VB	0
the	the	DT	0
cultures	cultures	NNS	0
of	of	IN	0
hyaluronan	hyaluronan	NN	B-NP
did	did	VBD	0
not	not	RB	0
have	have	VB	0
an	an	DT	0
effect	effect	NN	0
on	on	IN	0
the	the	DT	0
binding	binding	NN	0
.	.	.	0
These	These	DT	0
results	results	NNS	0
demonstrated	demonstrated	VBD	0
that	that	DT	0
removal	removal	NN	0
of	of	IN	0
heparin	heparin	JJ	0
/	/	NNP	0
HS	HS	NNP	0
from	from	IN	0
the	the	DT	0
cell	cell	NN	0
cultures	cultures	NNS	0
decreased	decreased	VBD	0
the	the	DT	0
pigment	pigment	NN	B-NP
epithelium	epithelium	NN	I-NP
derived	derived	VBN	I-NP
factor	factor	NN	I-NP
binding	binding	VBD	0
to	to	TO	0
receptors	receptors	VB	0
on	on	IN	0
y-79	y-79	NN	B-NP
cell	cell	NN	I-NP
.	.	.	0
Chlorate	Chlorate	NNP	B-NP
is	is	VBZ	0
a	a	DT	0
atp-sulfurylase	atp-sulfurylase	NN	B-NP
competitive	competitive	JJ	I-NP
inhibitor	inhibitor	NN	I-NP
,	,	,	0
and	and	CC	0
inhibition	inhibition	NN	0
of	of	IN	0
GAG	GAG	NNP	B-NP
sulfation	sulfation	NN	I-NP
in	in	IN	0
cell	cell	NN	0
cultures	cultures	NNS	0
can	can	MD	0
be	be	VB	0
achieved	achieved	VBN	0
by	by	IN	0
pretreatment	pretreatment	NN	B-NP
of	of	IN	0
the	the	DT	0
cultures	cultures	NNS	0
with	with	IN	0
30	30	CD	0
mM	mM	JJ	B-NP
sodium	sodium	NN	I-NP
chlorata	chlorata	NN	I-NP
[	[	-LRB-	0
21	21	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
effect	effect	NN	0
of	of	IN	0
undersulfated	undersulfated	JJ	B-NP
gag	gag	NN	I-NP
on	on	IN	0
the	the	DT	0
pigment	pigment	NN	B-NP
epithelium	epithelium	NN	I-NP
derived	derived	VBN	I-NP
factor	factor	NN	I-NP
binding	binding	VBD	0
to	to	TO	0
its	its	PRP$	0
receptor	receptor	NN	B-NP
was	was	VBD	0
examined	examined	VBN	0
.	.	.	0
Cells	Cells	NNS	0
pretreated	pretreated	VBN	0
with	with	IN	0
sodium	sodium	JJ	B-NP
chlorate	chlorate	NN	I-NP
did	did	VBD	0
not	not	RB	0
show	show	VB	0
changes	changes	NNS	0
in	in	IN	0
viability	viability	NN	0
or	or	CC	0
morphology	morphology	NNS	0
;	;	:	0
however	however	RB	0
,	,	,	0
the	the	DT	0
treatment	treatment	NN	0
resulted	resulted	VBD	0
in	in	IN	0
a	a	DT	0
decrease	decrease	NN	0
in	in	IN	0
the	the	DT	0
specific	specific	JJ	0
125I-PEDF	125I-PEDF	NN	0
binding	binding	VBG	0
to	to	TO	0
about	about	RB	0
35	35	CD	0
%	%	NN	0
relative	relative	JJ	0
to	to	TO	0
untreated	untreated	VB	0
controls	controls	NNS	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
5B	5B	NNP	0
)	)	-RRB-	0
.	.	.	0
Sodium	Sodium	JJ	B-NP
sulfate	sulfate	NN	I-NP
was	was	VBD	0
used	used	VBN	0
to	to	TO	0
recover	recover	VB	0
the	the	DT	0
loss	loss	NN	0
of	of	IN	0
GAG	GAG	NNP	B-NP
sulfation	sulfation	NN	I-NP
by	by	IN	0
chlorata	chlorata	NN	B-NP
increasing	increasing	VBG	0
the	the	DT	0
binding	binding	JJ	0
to	to	TO	0
55	55	CD	0
%	%	NN	0
maximal	maximal	NN	0
with	with	IN	0
10	10	CD	0
mM	mM	JJ	0
sulfate	sulfate	JJ	B-NP
addition	addition	NN	I-NP
.	.	.	0
The	The	DT	0
data	data	NNS	0
revealed	revealed	VBD	0
that	that	DT	0
inhibition	inhibition	NN	0
of	of	IN	0
sulfation	sulfation	NN	B-NP
of	of	IN	0
GAGs	GAGs	NNP	0
reduced	reduced	VBD	0
the	the	DT	0
pigment	pigment	NN	B-NP
epithelium	epithelium	NN	I-NP
derived	derived	VBN	I-NP
factor	factor	NN	I-NP
binding	binding	VBD	0
to	to	TO	0
y-79	y-79	NN	B-NP
cell	cell	NN	I-NP
cell-surface	cell-surface	JJ	I-NP
receptor	receptor	NN	I-NP
,	,	,	0
with	with	IN	0
about	about	IN	0
20	20	CD	0
%	%	NN	0
of	of	IN	0
specific	specific	JJ	0
inhibition	inhibition	NN	0
.	.	.	0
Thus	Thus	RB	0
,	,	,	0
these	these	DT	0
observation	observation	NN	B-NP
implied	implied	VBN	0
that	that	IN	0
HS	HS	NNP	B-NP
/	/	NNP	I-NP
heparin	heparin	NN	I-NP
might	might	MD	0
play	play	VB	0
a	a	DT	0
functional	functional	JJ	B-NP
role	role	NN	I-NP
in	in	IN	0
the	the	DT	0
binding	binding	NN	0
of	of	IN	0
pigment	pigment	NN	B-NP
epithelium	epithelium	NN	I-NP
derived	derived	VBN	I-NP
factor	factor	NN	I-NP
to	to	TO	0
its	its	PRP$	0
cell-surface	cell-surface	JJ	B-NP
receptor	receptor	NN	I-NP
.	.	.	0
Discussion	Discussion	NN	0
It	It	PRP	0
has	has	VBZ	0
been	been	VBN	0
proposed	proposed	VBN	0
that	that	IN	0
the	the	DT	0
GAG-binding	GAG-binding	JJ	0
property	property	NN	0
of	of	IN	0
pigment	pigment	NN	B-NP
epithelium	epithelium	NN	I-NP
derived	derived	VBN	I-NP
factor	factor	NN	I-NP
provides	provides	VBZ	0
the	the	DT	0
molecular	molecular	JJ	B-NP
basis	basis	NN	I-NP
for	for	IN	0
its	its	PRP$	0
association	association	NN	0
with	with	IN	0
extracellular	extracellular	JJ	B-NP
matrix	matrix	NN	I-NP
and	and	CC	0
may	may	MD	0
serve	serve	VB	0
to	to	TO	0
localize	localize	VB	0
PEDF	PEDF	JJ	B-NP
activity	activity	NN	I-NP
in	in	IN	0
the	the	DT	0
retina	retina	NN	B-NP
and	and	CC	0
CNS	CNS	NNP	B-NP
[	[	-LRB-	0
14	14	CD	0
19	19	CD	0
]	]	-RRB-	0
.	.	.	0
However	However	RB	0
,	,	,	0
the	the	DT	0
present	present	JJ	0
results	results	NNS	0
point	point	VBP	0
to	to	TO	0
direct	direct	JJ	0
effects	effects	NNS	0
these	these	DT	0
polysaccharide	polysaccharide	NN	B-NP
might	might	MD	0
have	have	VB	0
on	on	IN	0
the	the	DT	0
biochemical	biochemical	JJ	B-NP
interaction	interaction	NN	I-NP
between	between	IN	0
pigment	pigment	NN	B-NP
epithelium	epithelium	NN	I-NP
derived	derived	VBN	I-NP
factor	factor	NN	I-NP
and	and	CC	0
pedf	pedf	NN	B-NP
receptor	receptor	NN	I-NP
on	on	IN	0
the	the	DT	0
surfaces	surfaces	NN	0
of	of	IN	0
cells	cells	NNS	0
that	that	WDT	0
respond	respond	VBP	0
to	to	TO	0
this	this	DT	0
neurotrophic	neurotrophic	JJ	B-NP
factor	factor	NN	I-NP
.	.	.	0
We	We	PRP	0
have	have	VBP	0
shown	shown	VBN	0
that	that	IN	0
the	the	DT	0
binding	binding	NN	0
of	of	IN	0
pigment	pigment	NN	B-NP
epithelium	epithelium	NN	I-NP
derived	derived	VBN	I-NP
factor	factor	NN	I-NP
to	to	TO	0
receptors	receptors	VB	0
in	in	IN	0
retinoblastoma	retinoblastoma	NN	B-NP
cell	cell	NN	I-NP
is	is	VBZ	0
enhanced	enhanced	VBN	0
by	by	IN	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
extracellular	extracellular	NN	B-NP
heparin/hs-like	heparin/hs-like	NN	I-NP
gag	gag	NN	I-NP
,	,	,	0
which	which	WDT	0
can	can	MD	0
be	be	VB	0
found	found	VBN	0
in	in	IN	0
the	the	DT	0
culture	culture	NN	0
medium	medium	NN	0
of	of	IN	0
retinoblastoma	retinoblastoma	NN	B-NP
cell	cell	NN	I-NP
.	.	.	0
The	The	DT	0
fact	fact	NN	0
that	that	IN	0
the	the	DT	0
binding	binding	NN	0
of	of	IN	0
pigment	pigment	NN	B-NP
epithelium	epithelium	NN	I-NP
derived	derived	VBN	I-NP
factor	factor	NN	I-NP
to	to	TO	0
cell	cell	VB	0
surfaces	surfaces	JJ	0
decreases	decreases	NNS	0
with	with	IN	0
heparin	heparin	JJ	B-NP
/	/	NNP	I-NP
HS	HS	NNP	I-NP
depletion	depletion	NN	I-NP
,	,	,	0
implies	implies	VBZ	0
that	that	DT	0
heparin/h	heparin/h	NN	B-NP
molecule	molecule	NN	I-NP
might	might	MD	0
act	act	VB	0
as	as	IN	0
pedf-receptor	pedf-receptor	NN	B-NP
interaction	interaction	NN	I-NP
cofactor	cofactor	NN	I-NP
.	.	.	0
interaction	interaction	NN	B-NP
between	between	IN	0
pigment	pigment	NN	B-NP
epithelium	epithelium	NN	I-NP
derived	derived	VBN	I-NP
factor	factor	NN	I-NP
and	and	CC	0
extracellular	extracellular	JJ	B-NP
gag	gag	NN	I-NP
can	can	MD	0
also	also	RB	0
explain	explain	VB	0
the	the	DT	0
complex	complex	NN	0
formed	formed	VBN	0
by	by	IN	0
pigment	pigment	NN	B-NP
epithelium	epithelium	NN	I-NP
derived	derived	VBN	I-NP
factor	factor	NN	I-NP
with	with	IN	0
CM	CM	NNP	0
even	even	RB	0
after	after	IN	0
protease	protease	JJ	B-NP
treatment	treatment	NN	I-NP
of	of	IN	0
the	the	DT	0
latter	latter	NN	0
.	.	.	0
The	The	DT	0
pedf-heparin/h	pedf-heparin/h	NN	B-NP
complex	complex	NN	0
may	may	MD	0
somehow	somehow	RB	0
facilitate	facilitate	VB	0
encounters	encounters	VBN	0
between	between	IN	0
pigment	pigment	NN	B-NP
epithelium	epithelium	NN	I-NP
derived	derived	VBN	I-NP
factor	factor	NN	I-NP
and	and	CC	0
its	its	PRP$	0
receptor	receptor	NN	B-NP
,	,	,	0
e.g.	e.g.	NNP	0
,	,	,	0
by	by	IN	0
inducing	inducing	VBG	0
a	a	DT	0
conformational	conformational	JJ	B-NP
change	change	NN	I-NP
in	in	IN	0
pigment	pigment	NN	B-NP
epithelium	epithelium	NN	I-NP
derived	derived	VBN	I-NP
factor	factor	NN	I-NP
,	,	,	0
which	which	WDT	0
might	might	MD	0
accelerate	accelerate	VB	0
the	the	DT	0
ligand-receptor	ligand-receptor	JJ	B-NP
interaction	interaction	NN	I-NP
.	.	.	0
In	In	IN	0
addition	addition	NN	B-NP
,	,	,	0
the	the	DT	0
receptor	receptor	NN	B-NP
may	may	MD	0
also	also	RB	0
form	form	VB	0
a	a	DT	0
complex	complex	NN	0
with	with	IN	0
heparin	heparin	JJ	0
/	/	NNP	0
HS	HS	NNP	0
to	to	TO	0
facilitate	facilitate	VB	0
interaction	interaction	NN	B-NP
with	with	IN	0
the	the	DT	0
ligand	ligand	NN	B-NP
.	.	.	0
To	To	TO	0
our	our	PRP$	0
knowledge	knowledge	NN	0
,	,	,	0
this	this	DT	0
is	is	VBZ	0
the	the	DT	0
first	first	JJ	0
report	report	NN	0
on	on	IN	0
the	the	DT	0
production	production	NN	0
of	of	IN	0
GAGs	GAGs	JJ	0
by	by	IN	0
retinoblastoma	retinoblastoma	NN	B-NP
cell	cell	NN	I-NP
.	.	.	0
We	We	PRP	0
found	found	VBD	0
that	that	IN	0
these	these	DT	0
cells	cells	NNS	0
produce	produce	VBP	0
HS	HS	NNP	B-NP
/	/	NNP	I-NP
heparin	heparin	VBD	I-NP
secreted	secreted	VBN	0
into	into	IN	0
the	the	DT	0
culturing	culturing	JJ	B-NP
medium	medium	JJ	I-NP
.	.	.	0
The	The	DT	0
retina	retina	NN	B-NP
and	and	CC	0
malignant	malignant	JJ	0
solid	solid	JJ	0
tumors	tumors	NNS	0
also	also	RB	0
produce	produce	VB	0
the	the	DT	0
sulfated	sulfated	JJ	B-NP
gag	gag	NN	I-NP
[	[	-LRB-	0
1	1	CD	0
2	2	CD	0
22	22	CD	0
23	23	CD	0
24	24	CD	0
25	25	CD	0
26	26	CD	0
]	]	-RRB-	0
.	.	.	0
Although	Although	IN	0
h	h	NN	B-NP
are	are	VBP	0
mostly	mostly	RB	0
found	found	VBN	0
as	as	IN	0
proteoglycans	proteoglycans	VBG	0
associated	associated	VBN	0
with	with	IN	0
the	the	DT	0
basal	basal	JJ	B-NP
lamina	lamina	NN	I-NP
or	or	CC	0
the	the	DT	0
plasma	plasma	JJ	0
membrane	membrane	NN	0
,	,	,	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
HSs	HSs	JJ	0
in	in	IN	0
the	the	DT	0
culturing	culturing	JJ	B-NP
medium	medium	NN	I-NP
might	might	MD	0
be	be	VB	0
a	a	DT	0
result	result	NN	0
of	of	IN	0
shedding	shedding	VBG	0
or	or	CC	0
release	release	NN	0
of	of	IN	0
their	their	PRP$	0
extracellular	extracellular	JJ	B-NP
domain	domain	NN	I-NP
from	from	IN	0
the	the	DT	0
cell	cell	NN	0
membranes	membranes	NN	0
as	as	IN	0
soluble	soluble	JJ	0
components	components	NNS	0
.	.	.	0
Cell-associated	Cell-associated	NNP	0
h	h	NN	B-NP
proteoglycan	proteoglycan	NN	I-NP
can	can	MD	0
undergo	undergo	VB	0
regulated	regulated	VBN	0
shedding	shedding	VBG	0
from	from	IN	0
the	the	DT	0
membrane	membrane	NN	0
into	into	IN	0
the	the	DT	0
soluble	soluble	JJ	0
extracellular	extracellular	JJ	B-NP
matrix	matrix	NN	I-NP
or	or	CC	0
culturing	culturing	JJ	B-NP
medium	medium	NN	I-NP
converting	converting	VBG	0
the	the	DT	0
membrane	membrane	JJ	0
anchored	anchored	JJ	0
molecules	molecules	NNS	0
into	into	IN	0
soluble	soluble	JJ	0
effector	effector	NN	B-NP
[	[	-LRB-	0
1	1	CD	0
2	2	CD	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
the	the	DT	0
conditioned	conditioned	JJ	0
media	media	NNS	0
of	of	IN	0
all	all	PDT	0
the	the	DT	0
tested	tested	JJ	0
batches	batches	NNS	0
of	of	IN	0
retinoblastoma	retinoblastoma	NN	B-NP
cell	cell	NN	I-NP
,	,	,	0
we	we	PRP	0
detected	detected	VBD	0
heparin	heparin	JJ	0
and	and	CC	0
heparan	heparan	NN	B-NP
sulfate	sulfate	NN	I-NP
with	with	IN	0
binding	binding	JJ	0
pigment	pigment	NN	B-NP
epithelium	epithelium	NN	I-NP
derived	derived	VBN	I-NP
factor	factor	NN	I-NP
affinity	affinity	NN	I-NP
.	.	.	0
The	The	DT	0
estimated	estimated	JJ	0
concentration	concentration	NN	B-NP
of	of	IN	0
these	these	DT	0
GAGs	GAGs	JJ	0
in	in	IN	0
the	the	DT	0
media	media	NNS	0
may	may	MD	0
vary	vary	VB	0
with	with	IN	0
cell	cell	NN	0
density	density	NN	0
and	and	CC	0
conditioning	conditioning	JJ	0
time	time	NN	0
.	.	.	0
However	However	RB	0
,	,	,	0
under	under	IN	0
the	the	DT	0
conditions	conditions	NNS	0
used	used	VBN	0
,	,	,	0
they	they	PRP	0
were	were	VBD	0
within	within	IN	0
the	the	DT	0
linear	linear	JJ	0
range	range	NN	0
of	of	IN	0
HS-PEDF	HS-PEDF	JJ	B-NP
complex	complex	JJ	0
formation	formation	NN	0
(	(	-LRB-	0
EC	EC	NNP	B-NP
50	50	CD	0
=	=	SYM	0
40	40	CD	0
μg	μg	CD	B-NP
/	/	CD	I-NP
ml	ml	CD	I-NP
)	)	-RRB-	0
[	[	-LRB-	0
14	14	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
fact	fact	NN	0
that	that	IN	0
depletion	depletion	NN	0
of	of	IN	0
heparin/hs-like	heparin/hs-like	NN	B-NP
gag	gag	NN	I-NP
from	from	IN	0
the	the	DT	0
culturing	culturing	JJ	B-NP
media	media	NNS	I-NP
result	result	NN	I-NP
in	in	IN	0
inhibition	inhibition	NN	0
of	of	IN	0
pigment	pigment	NN	B-NP
epithelium	epithelium	NN	I-NP
derived	derived	VBN	I-NP
factor	factor	NN	I-NP
binding	binding	VBD	0
to	to	TO	0
cell	cell	NN	B-NP
surface	surface	NN	I-NP
receptor	receptor	NN	I-NP
points	points	NNS	0
to	to	TO	0
functional	functional	VB	B-NP
role	role	NN	I-NP
for	for	IN	0
these	these	DT	0
GAGs	GAGs	JJ	0
such	such	JJ	0
as	as	IN	0
those	those	DT	0
of	of	IN	0
pedf-receptor	pedf-receptor	NN	B-NP
interaction	interaction	NN	I-NP
positive	positive	JJ	I-NP
modulator	modulator	NN	I-NP
.	.	.	0
In	In	IN	0
this	this	DT	0
regard	regard	NN	0
,	,	,	0
we	we	PRP	0
observed	observed	VBD	0
that	that	DT	0
depletion	depletion	NN	0
from	from	IN	0
the	the	DT	0
heparin	heparin	NN	B-NP
y-79	y-79	NN	I-NP
cell	cell	NN	I-NP
culture	culture	NN	I-NP
with	with	IN	0
heparinase	heparinase	NN	B-NP
was	was	VBD	0
lower	lower	JJR	0
than	than	IN	0
those	those	DT	0
depleted	depleted	NN	0
of	of	IN	0
heparan	heparan	NN	B-NP
sulfate	sulfate	NN	I-NP
with	with	IN	0
heparitinase	heparitinase	NN	B-NP
,	,	,	0
suggesting	suggesting	VBG	0
that	that	IN	0
the	the	DT	0
retinoblastoma-derived	retinoblastoma-derived	JJ	B-NP
h	h	NN	I-NP
was	was	VBD	0
more	more	RBR	0
effective	effective	JJ	0
than	than	IN	0
the	the	DT	0
retinoblastoma-derived	retinoblastoma-derived	JJ	B-NP
heparin	heparin	NN	I-NP
.	.	.	0
This	This	DT	0
observation	observation	NN	0
can	can	MD	0
be	be	VB	0
explained	explained	VBN	0
by	by	IN	0
structural	structural	JJ	0
,	,	,	0
compositional	compositional	NN	B-NP
and	and	CC	0
functional	functional	JJ	B-NP
difference	difference	NN	I-NP
between	between	IN	0
heparin	heparin	NN	B-NP
and	and	CC	0
h	h	NN	B-NP
gag	gag	NN	I-NP
.	.	.	0
GAG-binding	GAG-binding	JJ	0
proteins	proteins	NNS	0
can	can	MD	0
be	be	VB	0
differentially	differentially	JJ	0
sensitive	sensitive	JJ	0
to	to	TO	0
variations	variations	NNS	0
in	in	IN	0
GAG	GAG	NNP	0
structure	structure	NN	0
[	[	-LRB-	0
27	27	CD	0
]	]	-RRB-	0
.	.	.	0
GAGs	GAGs	NNP	0
produced	produced	VBD	0
among	among	IN	0
different	different	JJ	0
cell	cell	NN	0
types	types	NNS	0
have	have	VBP	0
structural	structural	JJ	0
and	and	CC	0
compositional	compositional	JJ	B-NP
difference	difference	NN	I-NP
and	and	CC	0
structural	structural	JJ	B-NP
change	change	NN	I-NP
in	in	IN	0
GAGs	GAGs	NNS	0
are	are	VBP	0
known	known	VBN	0
to	to	TO	0
occur	occur	VB	0
in	in	IN	0
cells	cells	NNS	0
undergoing	undergoing	VBG	0
morphological	morphological	JJ	B-NP
differentiation	differentiation	NN	I-NP
and	and	CC	0
/	/	NNP	0
or	or	CC	0
malignant	malignant	JJ	0
transformation	transformation	NN	B-NP
[	[	-LRB-	0
28	28	CD	0
29	29	CD	0
30	30	CD	0
31	31	CD	0
]	]	-RRB-	0
.	.	.	0
Thus	Thus	RB	0
,	,	,	0
in	in	IN	0
the	the	DT	0
native	native	JJ	0
retina	retina	NN	B-NP
,	,	,	0
or	or	CC	0
other	other	JJ	0
tissue	tissue	NN	0
,	,	,	0
pedf-receptor	pedf-receptor	NN	B-NP
interaction	interaction	NN	I-NP
modulation	modulation	VBG	I-NP
may	may	MD	0
depend	depend	VB	0
on	on	IN	0
the	the	DT	0
expression	expression	NN	0
of	of	IN	0
GAGs	GAGs	NNP	0
,	,	,	0
which	which	WDT	0
occur	occur	VBP	0
during	during	IN	0
development	development	NN	0
and	and	CC	0
pathological	pathological	JJ	B-NP
condition	condition	NN	I-NP
.	.	.	0
Our	Our	PRP$	0
data	data	NNS	0
offer	offer	VBP	0
interesting	interesting	JJ	0
possibilities	possibilities	NNS	0
of	of	IN	0
regulation	regulation	NN	0
of	of	IN	0
the	the	DT	0
activity	activity	NN	0
of	of	IN	0
pigment	pigment	NN	B-NP
epithelium	epithelium	NN	I-NP
derived	derived	VBN	I-NP
factor	factor	NN	I-NP
.	.	.	0
The	The	DT	0
ratio	ratio	NN	0
and	and	CC	0
amount	amount	NN	0
of	of	IN	0
production	production	NN	0
of	of	IN	0
heparin	heparin	NN	B-NP
and	and	CC	0
heparan	heparan	NN	B-NP
sulfate	sulfate	NN	I-NP
by	by	IN	0
cells	cells	NNS	0
bearing	bearing	VBG	B-NP
pedf	pedf	NN	I-NP
receptor	receptor	NN	I-NP
may	may	MD	0
be	be	VB	0
an	an	DT	0
important	important	JJ	0
mechanism	mechanism	NN	0
to	to	TO	0
control	control	VB	0
the	the	DT	0
activity	activity	NN	0
of	of	IN	0
pigment	pigment	NN	B-NP
epithelium	epithelium	NN	I-NP
derived	derived	VBN	I-NP
factor	factor	NN	I-NP
as	as	RB	0
is	is	VBZ	0
the	the	DT	0
modulation	modulation	NN	B-NP
of	of	IN	0
the	the	DT	0
rate	rate	NN	0
of	of	IN	0
expression	expression	NN	0
of	of	IN	0
pedf	pedf	NN	B-NP
receptor	receptor	NN	I-NP
.	.	.	0
The	The	DT	0
data	data	NNS	0
obtained	obtained	VBD	0
so	so	RB	0
far	far	RB	0
on	on	IN	0
the	the	DT	0
action	action	NN	0
of	of	IN	0
pigment	pigment	NN	B-NP
epithelium	epithelium	NN	I-NP
derived	derived	VBN	I-NP
factor	factor	NN	I-NP
on	on	IN	0
different	different	JJ	0
cells	cells	NNS	0
may	may	MD	0
have	have	VB	0
not	not	RB	0
considered	considered	VBN	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
these	these	DT	0
cofactor	cofactor	NN	B-NP
in	in	IN	0
the	the	DT	0
media	media	NNS	0
.	.	.	0
The	The	DT	0
binding	binding	NN	0
of	of	IN	0
GAGs	GAGs	JJ	0
to	to	TO	0
pigment	pigment	NN	B-NP
epithelium	epithelium	NN	I-NP
derived	derived	VBN	I-NP
factor	factor	NN	I-NP
that	that	WDT	0
modulate	modulate	VBP	0
the	the	DT	0
binding	binding	NN	0
of	of	IN	0
these	these	DT	0
factors	factors	NNS	0
to	to	TO	0
its	its	PRP$	0
receptor	receptor	NN	B-NP
opens	opens	VBZ	0
also	also	RB	0
the	the	DT	0
possibility	possibility	NN	0
that	that	IN	0
different	different	JJ	0
GAGs	GAGs	NN	0
may	may	MD	0
modulate	modulate	VB	0
differently	differently	RB	0
the	the	DT	0
pigment	pigment	NN	B-NP
epithelium	epithelium	NN	I-NP
derived	derived	VBN	I-NP
factor	factor	NN	I-NP
affinity	affinity	NN	I-NP
for	for	IN	0
its	its	PRP$	0
receptor	receptor	NN	B-NP
,	,	,	0
by	by	IN	0
increasing	increasing	VBG	0
or	or	CC	0
even	even	RB	0
decreasing	decreasing	VBG	0
it	it	PRP	0
in	in	IN	0
some	some	DT	0
cases	cases	NNS	0
.	.	.	0
Finally	Finally	RB	0
,	,	,	0
the	the	DT	0
fact	fact	NN	0
that	that	IN	0
the	the	DT	0
GAG	GAG	NNP	0
and	and	CC	0
receptor	receptor	JJ	B-NP
binding	binding	JJ	I-NP
region	region	NN	I-NP
are	are	VBP	0
on	on	IN	0
opposite	opposite	JJ	0
regions	regions	NNS	0
of	of	IN	0
the	the	DT	0
PEDF	PEDF	NNP	B-NP
molecule	molecule	NN	I-NP
,	,	,	0
suggest	suggest	VBP	0
the	the	DT	0
possibility	possibility	NN	0
of	of	IN	0
the	the	DT	0
existence	existence	NN	0
of	of	IN	0
pedf	pedf	NN	B-NP
mutant	mutant	NN	I-NP
or	or	CC	0
engineered	engineered	JJ	0
variants	variants	NN	0
that	that	IN	0
,	,	,	0
having	having	VBG	0
lost	lost	VBN	0
or	or	CC	0
decreased	decreased	VBD	0
GAG-binding	GAG-binding	JJ	0
capabilities	capabilities	NNS	0
,	,	,	0
still	still	RB	0
show	show	VB	0
high	high	JJ	0
pedf	pedf	NN	B-NP
receptor	receptor	NN	I-NP
affinity	affinity	NN	I-NP
in	in	IN	0
a	a	DT	0
way	way	NN	0
not	not	RB	0
dependent	dependent	JJ	0
upon	upon	IN	0
GAGs	GAGs	JJ	0
content	content	NN	0
or	or	CC	0
composition	composition	NN	0
.	.	.	0
These	These	DT	0
possibilities	possibilities	NNS	0
are	are	VBP	0
discussed	discussed	VBN	0
under	under	IN	0
the	the	DT	0
consideration	consideration	NN	B-NP
that	that	IN	0
some	some	DT	0
of	of	IN	0
them	them	PRP	0
may	may	MD	0
have	have	VB	0
important	important	JJ	0
implication	implication	NN	B-NP
if	if	IN	0
pigment	pigment	NN	B-NP
epithelium	epithelium	NN	I-NP
derived	derived	VBN	I-NP
factor	factor	NN	I-NP
,	,	,	0
or	or	CC	0
molecules	molecules	NNS	0
derived	derived	VBN	0
from	from	IN	0
it	it	PRP	0
,	,	,	0
are	are	VBP	0
to	to	TO	0
be	be	VB	0
used	used	VBN	0
in	in	IN	0
the	the	DT	0
future	future	NN	0
as	as	IN	0
therapeutic	therapeutic	JJ	B-NP
agent	agent	NN	I-NP
.	.	.	0
The	The	DT	0
primary	primary	JJ	B-NP
consequence	consequence	NN	I-NP
of	of	IN	0
reducing	reducing	VBG	0
the	the	DT	0
heparin	heparin	JJ	0
/	/	NNP	0
HS	HS	NNP	0
and	and	CC	0
its	its	PRP$	0
sulfation	sulfation	NN	B-NP
was	was	VBD	0
to	to	TO	0
minimize	minimize	VB	0
a	a	DT	0
binding	binding	JJ	0
site	site	NN	0
required	required	VBN	0
for	for	IN	0
PEDF	PEDF	NNP	B-NP
activity	activity	NN	I-NP
.	.	.	0
Although	Although	IN	0
GAGs	GAGs	JJ	0
store	store	NN	B-NP
PEDF	PEDF	NN	I-NP
in	in	IN	0
the	the	DT	0
extracellular	extracellular	JJ	B-NP
matrix	matrix	NN	I-NP
[	[	-LRB-	0
14	14	CD	0
]	]	-RRB-	0
,	,	,	0
a	a	DT	0
more	more	RBR	0
direct	direct	JJ	0
mechanism	mechanism	NN	0
appears	appears	VBZ	0
necessary	necessary	JJ	0
,	,	,	0
namely	namely	RB	0
,	,	,	0
its	its	PRP$	0
participation	participation	NN	B-NP
in	in	IN	0
the	the	DT	0
binding	binding	NN	0
of	of	IN	0
pigment	pigment	NN	B-NP
epithelium	epithelium	NN	I-NP
derived	derived	VBN	I-NP
factor	factor	NN	I-NP
to	to	TO	0
its	its	PRP$	0
receptor	receptor	NN	B-NP
.	.	.	0
In	In	IN	0
a	a	DT	0
pigment	pigment	NN	B-NP
epithelium	epithelium	NN	I-NP
derived	derived	VBN	I-NP
factor	factor	NN	I-NP
spatial	spatial	JJ	I-NP
structure	structure	NN	I-NP
,	,	,	0
the	the	DT	0
pedf	pedf	NN	B-NP
map	map	NN	I-NP
heparin/h	heparin/h	NN	I-NP
binding	binding	JJ	I-NP
domain	domain	NN	I-NP
to	to	TO	0
the	the	DT	0
opposite	opposite	JJ	0
side	side	NN	0
of	of	IN	0
the	the	DT	0
neurotrophic	neurotrophic	JJ	0
active	active	JJ	0
region	region	NN	0
[	[	-LRB-	0
20	20	CD	0
]	]	-RRB-	0
,	,	,	0
allowing	allowing	VBG	0
distinct	distinct	JJ	0
and	and	CC	0
non-overlapping	non-overlapping	JJ	B-NP
interaction	interaction	NN	I-NP
with	with	IN	0
heparin	heparin	JJ	0
/	/	NNP	0
HS	HS	NNP	0
on	on	IN	0
one	one	CD	0
side	side	NN	0
of	of	IN	0
the	the	DT	0
protein	protein	NN	B-NP
,	,	,	0
and	and	CC	0
with	with	IN	0
the	the	DT	0
neurotrophic	neurotrophic	JJ	B-NP
receptor	receptor	NN	I-NP
on	on	IN	0
its	its	PRP$	0
opposite	opposite	JJ	0
side	side	NN	0
.	.	.	0
Our	Our	PRP$	0
data	data	NNS	0
suggest	suggest	VBP	0
that	that	IN	0
the	the	DT	0
pigment	pigment	NN	B-NP
epithelium	epithelium	NN	I-NP
derived	derived	VBN	I-NP
factor	factor	NN	I-NP
cell	cell	NN	I-NP
surface	surface	NN	I-NP
receptor	receptor	NN	I-NP
intrinsic	intrinsic	JJ	I-NP
affinity	affinity	NN	I-NP
appears	appears	VBZ	0
low	low	JJ	0
,	,	,	0
whereas	whereas	IN	0
the	the	DT	0
heparin	heparin	JJ	B-NP
/	/	CD	I-NP
HS-PEDF	HS-PEDF	JJ	I-NP
complex	complex	NN	I-NP
is	is	VBZ	0
recognized	recognized	VBN	0
with	with	IN	0
high	high	JJ	0
affinity	affinity	NN	B-NP
.	.	.	0
In	In	IN	0
addition	addition	NN	B-NP
,	,	,	0
a	a	DT	0
direct	direct	JJ	0
interaction	interaction	NN	0
between	between	IN	0
the	the	DT	0
receptor	receptor	NN	B-NP
and	and	CC	0
GAGs	GAGs	NNP	0
may	may	MD	0
also	also	RB	0
be	be	VB	0
necessary	necessary	JJ	0
.	.	.	0
Although	Although	IN	0
details	details	NNS	0
of	of	IN	0
the	the	DT	0
mechanism	mechanism	NN	0
remain	remain	VBP	0
to	to	TO	0
be	be	VB	0
revealed	revealed	VBN	0
,	,	,	0
it	it	PRP	0
is	is	VBZ	0
clear	clear	JJ	0
that	that	IN	0
heparin	heparin	JJ	0
/	/	NNP	0
HS	HS	NNP	0
is	is	VBZ	0
required	required	VBN	0
for	for	IN	0
the	the	DT	0
first	first	JJ	0
step	step	NN	0
of	of	IN	0
the	the	DT	0
pigment	pigment	NN	B-NP
epithelium	epithelium	NN	I-NP
derived	derived	VBN	I-NP
factor	factor	NN	I-NP
neurotrophic	neurotrophic	JJ	I-NP
activity	activity	NN	I-NP
,	,	,	0
namely	namely	RB	0
the	the	DT	0
encounters	encounters	NN	0
with	with	IN	0
its	its	PRP$	0
receptor	receptor	NN	B-NP
at	at	IN	0
the	the	DT	0
cell	cell	NN	0
surface	surface	NN	0
.	.	.	0
The	The	DT	0
differentiation	differentiation	NN	B-NP
and	and	CC	0
survival	survival	NN	0
of	of	IN	0
cells	cells	NNS	0
in	in	IN	0
vivo	vivo	NN	B-NP
may	may	MD	0
be	be	VB	0
regulated	regulated	VBN	0
not	not	RB	0
only	only	RB	0
by	by	IN	0
the	the	DT	0
expression	expression	NN	0
of	of	IN	0
pigment	pigment	NN	B-NP
epithelium	epithelium	NN	I-NP
derived	derived	VBN	I-NP
factor	factor	NN	I-NP
and	and	CC	0
its	its	PRP$	0
receptor	receptor	NN	B-NP
but	but	CC	0
also	also	RB	0
by	by	IN	0
the	the	DT	0
temporal	temporal	NN	0
and	and	CC	0
spatial	spatial	JJ	B-NP
expression	expression	NN	I-NP
of	of	IN	0
GAGs	GAGs	JJ	0
.	.	.	0
Methods	Methods	NNP	0
Materials	Materials	NNPS	0
Heparin	Heparin	NNP	B-NP
purified	purified	NN	I-NP
from	from	IN	0
bovine	bovine	JJ	B-NP
intestinal	intestinal	JJ	I-NP
mucosa	mucosa	NN	I-NP
,	,	,	0
chondroitin	chondroitin	NN	B-NP
sulfate	sulfate	NN	I-NP
A	A	NNP	0
,	,	,	0
B	B	NNP	0
and	and	CC	0
C	C	NNP	0
,	,	,	0
chondroitinase	chondroitinase	VBG	0
ABC	ABC	NNP	B-NP
,	,	,	0
sodium	sodium	JJ	B-NP
chlorate	chlorate	NN	I-NP
,	,	,	0
and	and	CC	0
Toluidine	Toluidine	NNP	B-NP
Blue-O	Blue-O	NNP	I-NP
were	were	VBD	0
purchased	purchased	VBN	0
from	from	IN	0
Sigma	Sigma	NNP	B-NP
.	.	.	0
Subtilisin	Subtilisin	NNP	B-NP
was	was	VBD	0
from	from	IN	0
Boehringer	Boehringer	NNP	0
Mannheim	Mannheim	NNP	0
.	.	.	0
Heparitinase	Heparitinase	NNP	B-NP
(	(	-LRB-	0
E.C.4.2.2.8	E.C.4.2.2.8	NNP	0
)	)	-RRB-	0
and	and	CC	0
heparinasa	heparinasa	NN	B-NP
(	(	-LRB-	0
E.C.4.2.2.7	E.C.4.2.2.7	NNP	0
)	)	-RRB-	0
purified	purified	NN	0
from	from	IN	0
Flavobacterium	Flavobacterium	NNP	B-NP
heparinum	heparinum	NN	I-NP
were	were	VBD	0
from	from	IN	0
ICN	ICN	NNP	B-NP
Biomedicals	Biomedicals	NNP	0
,	,	,	0
Inc.	Inc.	NNP	0
and	and	CC	0
alternatively	alternatively	RB	0
from	from	IN	0
Seikagaku	Seikagaku	NNP	B-NP
.	.	.	0
Heparan	Heparan	JJ	B-NP
sulfata	sulfata	NN	I-NP
(	(	-LRB-	0
heparan	heparan	NN	B-NP
sulfate	sulfate	NN	I-NP
)	)	-RRB-	0
purified	purified	NN	0
from	from	IN	0
bovine	bovine	JJ	B-NP
kidney	kidney	NN	I-NP
was	was	VBD	0
from	from	IN	0
Seikagaku	Seikagaku	NNP	B-NP
,	,	,	0
hyaluronidasa	hyaluronidasa	NN	B-NP
(	(	-LRB-	0
E.C.4.2.2.1	E.C.4.2.2.1	NNP	0
)	)	-RRB-	0
purified	purified	NN	0
from	from	IN	0
hyalurolyticus	hyalurolyticus	NN	B-NP
streptomyce	streptomyce	NN	I-NP
from	from	IN	0
ICN	ICN	NNP	B-NP
Pharmaceuticals	Pharmaceuticals	NNP	0
,	,	,	0
Coomassie	Coomassie	NNP	B-NP
Brilliant	Brilliant	NNP	I-NP
Blue	Blue	NNP	I-NP
from	from	IN	0
BioRad	BioRad	NNP	B-NP
,	,	,	0
and	and	CC	0
Q-Sepharose	Q-Sepharose	JJ	B-NP
from	from	IN	0
Pharmacia	Pharmacia	NNP	B-NP
.	.	.	0
Recombinant	Recombinant	NNP	B-NP
PEDF	PEDF	NNP	I-NP
was	was	VBD	0
purified	purified	VBN	0
from	from	IN	0
BHK	BHK	NNP	B-NP
cells	cells	NNS	0
containing	containing	VBG	0
an	an	DT	0
expression	expression	NN	B-NP
vector	vector	NN	I-NP
with	with	IN	0
human	human	JJ	0
PEDF	PEDF	NNP	B-NP
cDNA	cDNA	NNP	I-NP
,	,	,	0
as	as	RB	0
previously	previously	RB	0
described	described	VBN	0
[	[	-LRB-	0
19	19	CD	0
]	]	-RRB-	0
.	.	.	0
Preparation	Preparation	NN	B-NP
of	of	IN	0
conditioned	conditioned	JJ	0
media	media	NNS	0
human	human	JJ	B-NP
retinoblastoma	retinoblastoma	NN	I-NP
y-79	y-79	NN	I-NP
cell	cell	NN	I-NP
(	(	-LRB-	0
0.45-5	0.45-5	CD	0
×	×	CD	0
10	10	CD	0
6cells	6cells	CD	0
/	/	CD	0
ml	ml	CD	0
)	)	-RRB-	0
were	were	VBD	0
cultured	cultured	VBN	0
in	in	IN	0
defined	defined	JJ	0
media	media	NNS	0
(	(	-LRB-	0
MEM	MEM	NNP	B-NP
containing	containing	VBG	0
10	10	CD	0
mm	mm	NN	B-NP
hepe	hepe	NN	I-NP
,	,	,	0
1	1	CD	0
mM	mM	JJ	B-NP
Na-pyruvate	Na-pyruvate	NN	I-NP
,	,	,	0
0.1	0.1	CD	0
mM	mM	JJ	B-NP
non-essential	non-essential	JJ	I-NP
amino	amino	JJ	0
acids	acids	NNS	0
,	,	,	0
1	1	CD	0
mM	mM	JJ	B-NP
L-glutamine	L-glutamine	NN	I-NP
,	,	,	0
1	1	CD	0
%	%	NN	0
penicillin	penicillin	NN	B-NP
/	/	NN	I-NP
streptomycin	streptomycin	NN	I-NP
(	(	-LRB-	0
lifetechnology	lifetechnology	NN	B-NP
)	)	-RRB-	0
)	)	-RRB-	0
at	at	IN	0
37°C	37°C	CD	0
for	for	IN	0
16-24	16-24	CD	0
h.	h.	NN	B-NP
medium	medium	JJ	I-NP
exposed	exposed	VBN	0
to	to	TO	0
these	these	DT	0
conditions	conditions	NNS	0
is	is	VBZ	0
referred	referred	VBN	0
as	as	IN	0
CM	CM	NNP	0
.	.	.	0
CM	CM	NNP	0
was	was	VBD	0
separated	separated	VBN	0
from	from	IN	0
cells	cells	NNS	0
by	by	IN	0
centrifugation	centrifugation	NN	B-NP
(	(	-LRB-	0
1000	1000	CD	0
×	×	CD	0
g	g	NN	0
for	for	IN	0
5	5	CD	0
min	min	NN	B-NP
at	at	IN	0
4°C	4°C	CD	0
)	)	-RRB-	0
and	and	CC	0
concentrated	concentrated	VBN	0
by	by	IN	0
ultrafiltration	ultrafiltration	NN	B-NP
using	using	VBG	0
membrane	membrane	JJ	B-NP
filter	filter	NN	I-NP
with	with	IN	0
MWCO	MWCO	NNP	B-NP
=	=	SYM	0
10,000	10,000	CD	0
(	(	-LRB-	0
amicon	amicon	NN	B-NP
ym10	ym10	NN	I-NP
filter	filter	NN	I-NP
)	)	-RRB-	0
.	.	.	0
GAGs	GAGs	NNP	B-NP
/	/	NNP	I-NP
polyanions	polyanions	NN	I-NP
purification	purification	NN	I-NP
was	was	VBD	0
performed	performed	VBN	0
as	as	RB	0
follows	follows	VBZ	0
:	:	:	0
concentrated	concentrated	VBD	0
CM	CM	NNP	0
(	(	-LRB-	0
15	15	CD	0
ml	ml	CD	0
)	)	-RRB-	0
was	was	VBD	0
dialyzed	dialyzed	VBN	0
against	against	IN	0
buffer	buffer	JJ	B-NP
Q	Q	NNP	I-NP
(	(	-LRB-	0
50	50	CD	0
mM	mM	JJ	B-NP
Tris-HCl	Tris-HCl	NN	I-NP
,	,	,	0
pH	pH	NNP	B-NP
8.0	8.0	NNP	0
,	,	,	0
0.2	0.2	CD	0
M	M	NNP	0
NaCl	NaCl	NNP	B-NP
,	,	,	0
6	6	CD	0
M	M	NNP	0
Urea	Urea	NNP	B-NP
,	,	,	0
0.5	0.5	CD	0
%	%	NN	0
CHAPS	CHAPS	NNP	0
)	)	-RRB-	0
,	,	,	0
filtered	filtered	VBG	0
through	through	IN	0
a	a	DT	0
0.4	0.4	CD	0
micron	micron	CD	0
membrane	membrane	NNS	0
and	and	CC	0
its	its	PRP$	0
soluble	soluble	JJ	0
components	components	NNS	0
subjected	subjected	VBN	0
to	to	TO	0
anion-exchange	anion-exchange	JJ	B-NP
column	column	NN	I-NP
chromatography	chromatography	VBZ	0
using	using	VBG	0
Q-Sepharose	Q-Sepharose	JJ	B-NP
Fast	Fast	NNP	0
Flow	Flow	NNP	0
(	(	-LRB-	0
1	1	CD	0
ml	ml	JJ	B-NP
bed	bed	NN	I-NP
volume	volume	NN	I-NP
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
column	column	NN	0
was	was	VBD	0
washed	washed	VBN	0
with	with	IN	0
15-column	15-column	CD	0
volumes	volumes	NNS	0
of	of	IN	0
buffer	buffer	JJ	B-NP
Q	Q	NNP	I-NP
,	,	,	0
the	the	DT	0
bound	bound	JJ	0
material	material	NN	0
eluted	eluted	NN	0
with	with	IN	0
1.2	1.2	CD	0
M	M	NNP	0
NaCl	NaCl	NNP	B-NP
and	and	CC	0
termed	termed	FW	0
CM	CM	FW	0
a	a	FW	0
.	.	.	0
Alternatively	Alternatively	RB	0
,	,	,	0
a	a	DT	0
DEAE-Sephacel	DEAE-Sephacel	JJ	B-NP
column	column	NN	I-NP
was	was	VBD	0
used	used	VBN	0
.	.	.	0
PEDF-affinity	PEDF-affinity	JJ	B-NP
column	column	NN	I-NP
chromatography	chromatography	NN	I-NP
To	To	TO	0
identify	identify	VB	0
components	components	NNS	0
with	with	IN	0
PEDF-binding	PEDF-binding	JJ	B-NP
affinity	affinity	NN	I-NP
,	,	,	0
purified	purified	JJ	0
recombinant	recombinant	JJ	0
protein	protein	NN	B-NP
was	was	VBD	0
used	used	VBN	0
to	to	TO	0
prepare	prepare	VB	0
PEDF-affinity	PEDF-affinity	JJ	B-NP
resin	resin	NN	I-NP
with	with	IN	0
3	3	CD	0
M	M	NNP	0
Emphaze™	Emphaze™	NNP	B-NP
Biosupport	Biosupport	NNP	B-NP
Medium	Medium	NNP	I-NP
(	(	-LRB-	0
Pierce	Pierce	NNP	0
Chemical	Chemical	NNP	0
)	)	-RRB-	0
[	[	-LRB-	0
18	18	CD	0
]	]	-RRB-	0
.	.	.	0
CM	CM	NNP	0
awas	awas	VBD	0
dialyzed	dialyzed	VBN	0
against	against	IN	0
buffer	buffer	JJ	B-NP
P	P	NN	I-NP
(	(	-LRB-	0
20	20	CD	0
mM	mM	JJ	B-NP
sodium	sodium	NN	I-NP
phosphate	phosphate	VBP	I-NP
pH	pH	JJ	0
7	7	CD	0
,	,	,	0
150	150	CD	0
mM	mM	JJ	B-NP
NaCl	NaCl	NN	I-NP
,	,	,	0
0.5	0.5	CD	0
%	%	NN	0
CHAPS	CHAPS	NNP	0
)	)	-RRB-	0
and	and	CC	0
filtrated	filtrated	NN	0
through	through	IN	0
0.4	0.4	CD	0
μm	μm	CD	B-NP
filter	filter	NN	I-NP
.	.	.	0
The	The	DT	0
soluble	soluble	JJ	0
dialysate	dialysate	NN	B-NP
was	was	VBD	0
mixed	mixed	VBN	0
with	with	IN	0
PEDF-resin	PEDF-resin	NNP	B-NP
(	(	-LRB-	0
6	6	CD	0
mg	mg	NN	B-NP
PEDF	PEDF	NN	I-NP
/	/	NN	I-NP
ml	ml	NN	I-NP
resin	resin	NN	I-NP
)	)	-RRB-	0
at	at	IN	0
a	a	DT	0
2	2	CD	0
:	:	:	0
1	1	CD	0
volume-to-volume	volume-to-volume	JJ	B-NP
ratio	ratio	NN	I-NP
and	and	CC	0
incubated	incubated	NN	0
at	at	IN	0
4°C	4°C	CD	0
with	with	IN	0
gentle	gentle	JJ	0
rocking	rocking	NN	0
for	for	IN	0
16	16	CD	0
h	h	NNS	0
.	.	.	0
The	The	DT	0
mixture	mixture	NN	0
was	was	VBD	0
packed	packed	VBN	0
into	into	IN	0
a	a	DT	0
10	10	CD	0
ml	ml	FW	0
Polyprep	Polyprep	NN	B-NP
chromatography	chromatography	NN	I-NP
column	column	NN	I-NP
(	(	-LRB-	0
Bio-Rad	Bio-Rad	NNP	B-NP
)	)	-RRB-	0
and	and	CC	0
washed	washed	VBN	0
with	with	IN	0
10-column	10-column	CD	0
volumes	volumes	NNS	0
of	of	IN	0
buffer	buffer	JJ	B-NP
P.	P.	NNP	I-NP
The	The	DT	0
bound	bound	JJ	0
material	material	NN	0
was	was	VBD	0
eluted	eluted	VBN	0
with	with	IN	0
10-column	10-column	CD	0
volumes	volumes	NNS	0
of	of	IN	0
3	3	CD	0
M	M	NNP	0
NaCl	NaCl	NNP	B-NP
,	,	,	0
desalted	desalted	VBG	0
with	with	IN	0
20	20	CD	0
mM	mM	JJ	B-NP
Tris-HCl	Tris-HCl	JJ	I-NP
pH	pH	JJ	0
8.0	8.0	NN	0
,	,	,	0
10	10	CD	0
%	%	NN	0
glycerol	glycerol	NN	B-NP
,	,	,	0
treated	treated	VBN	0
for	for	IN	0
protein	protein	NN	B-NP
depletion	depletion	NN	I-NP
,	,	,	0
dialyzed	dialyzed	VBG	0
against	against	IN	0
deionized	deionized	JJ	B-NP
water	water	NN	I-NP
,	,	,	0
lyophilized	lyophilized	NN	0
and	and	CC	0
resuspended	resuspended	NN	B-NP
in	in	IN	0
deionized	deionized	JJ	B-NP
water	water	NN	I-NP
.	.	.	0
The	The	DT	0
final	final	JJ	B-NP
sample	sample	NN	I-NP
was	was	VBD	0
termed	termed	VBN	0
CM	CM	NNP	0
pigment	pigment	NN	B-NP
epithelium	epithelium	NN	I-NP
derived	derived	VBN	I-NP
factor	factor	NN	I-NP
.	.	.	0
About	About	IN	0
100	100	CD	0
μl	μl	NN	B-NP
of	of	IN	0
CM	CM	NNP	0
PEDFwere	PEDFwere	NNP	B-NP
obtained	obtained	VBD	0
from	from	IN	0
100	100	CD	0
ml	ml	NN	0
of	of	IN	0
CM	CM	NNP	0
.	.	.	0
Alternatively	Alternatively	RB	0
,	,	,	0
concentrated	concentrated	VBD	0
CM	CM	NNP	0
was	was	VBD	0
used	used	VBN	0
as	as	IN	0
starting	starting	VBG	B-NP
material	material	NN	I-NP
and	and	CC	0
protein	protein	NN	B-NP
depletion	depletion	NN	I-NP
was	was	VBD	0
omitted	omitted	VBN	0
.	.	.	0
binding	binding	JJ	B-NP
assay	assay	NN	I-NP
radioligand	radioligand	NN	I-NP
pigment	pigment	NN	B-NP
epithelium	epithelium	NN	I-NP
derived	derived	VBN	I-NP
factor	factor	NN	I-NP
binding	binding	FW	0
to	to	TO	0
cell-surface	cell-surface	JJ	B-NP
receptor	receptor	NN	I-NP
was	was	VBD	0
assayed	assayed	VBN	0
using	using	VBG	0
biologically	biologically	JJ	0
active	active	JJ	0
radioligand	radioligand	JJ	0
125I-PEDF	125I-PEDF	NN	0
and	and	CC	0
y-79	y-79	NN	B-NP
cell	cell	NN	I-NP
[	[	-LRB-	0
18	18	CD	0
]	]	-RRB-	0
by	by	IN	0
a	a	DT	0
widely-used	widely-used	JJ	0
method	method	NN	0
with	with	IN	0
a	a	DT	0
mechanism	mechanism	NN	0
of	of	IN	0
retention	retention	NN	0
of	of	IN	0
receptor	receptor	NN	B-NP
on	on	IN	0
polyethylenimine-treated	polyethylenimine-treated	JJ	B-NP
glass-fiber	glass-fiber	JJ	I-NP
filter	filter	NN	I-NP
based	based	VBN	0
mainly	mainly	RB	0
on	on	IN	0
ionic	ionic	JJ	B-NP
interaction	interaction	NN	I-NP
[	[	-LRB-	0
32	32	CD	0
]	]	-RRB-	0
.	.	.	0
Polyethylenimine	Polyethylenimine	NNP	B-NP
binds	binds	VBD	0
strongly	strongly	RB	0
to	to	TO	0
glass	glass	NN	0
,	,	,	0
which	which	WDT	0
is	is	VBZ	0
negatively	negatively	RB	0
charged	charged	VBN	0
and	and	CC	0
integral	integral	JJ	B-NP
membrane	membrane	JJ	I-NP
protein	protein	NN	I-NP
tend	tend	VBP	0
to	to	TO	0
be	be	VB	0
acidic	acidic	NNS	0
.	.	.	0
The	The	DT	0
resultant	resultant	JJ	0
polycationic	polycationic	JJ	B-NP
polyethylenimine-coated	polyethylenimine-coated	JJ	I-NP
glass	glass	NN	I-NP
can	can	MD	0
retain	retain	VB	0
cell	cell	NN	0
membranes	membranes	VBZ	0
due	due	JJ	0
to	to	TO	0
their	their	PRP$	0
negative	negative	JJ	B-NP
charge	charge	NN	I-NP
.	.	.	0
Because	Because	IN	0
binding	binding	VBG	0
of	of	IN	0
cell-surface	cell-surface	JJ	B-NP
receptor	receptor	NN	I-NP
to	to	TO	0
polyethylenimine	polyethylenimine	VB	0
filters	filters	NNS	0
is	is	VBZ	0
rather	rather	RB	0
insensitive	insensitive	VBN	0
to	to	TO	0
ionic	ionic	VB	0
strength	strength	NN	0
,	,	,	0
the	the	DT	0
ionic	ionic	JJ	B-NP
phenomenon	phenomenon	NN	I-NP
is	is	VBZ	0
thought	thought	VBN	0
to	to	TO	0
be	be	VB	0
supplemented	supplemented	VBN	0
by	by	IN	0
hydrophobic	hydrophobic	JJ	B-NP
force	force	NN	I-NP
and	and	CC	0
hydrogen	hydrogen	NN	B-NP
binding	binding	NNS	0
[	[	-LRB-	0
32	32	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
method	method	NN	0
used	used	VBN	0
with	with	IN	0
y-79	y-79	NN	B-NP
cell	cell	NN	I-NP
and	and	CC	0
radiolabeled	radiolabeled	JJ	B-NP
PEDF	PEDF	NNP	I-NP
has	has	VBZ	0
been	been	VBN	0
described	described	VBN	0
before	before	IN	0
in	in	IN	0
detail	detail	NN	0
[	[	-LRB-	0
18	18	CD	0
]	]	-RRB-	0
.	.	.	0
Briefly	Briefly	RB	0
,	,	,	0
cells	cells	NNS	0
cultured	cultured	VBP	0
overnight	overnight	RB	0
in	in	IN	0
serum-deprived	serum-deprived	JJ	0
medium	medium	NN	0
at	at	IN	0
37°C	37°C	NNP	0
were	were	VBD	0
transferred	transferred	VBN	0
to	to	TO	0
ice	ice	CD	B-NP
/	/	CD	I-NP
water	water	NN	I-NP
bath	bath	NN	I-NP
for	for	IN	0
10	10	CD	0
minutes	minutes	NNS	0
before	before	IN	0
the	the	DT	0
ligand	ligand	NN	B-NP
addition	addition	NN	I-NP
.	.	.	0
The	The	DT	0
containing	containing	VBG	B-NP
cell	cell	NN	I-NP
suspension	suspension	NN	I-NP
reaction	reaction	NN	I-NP
mixture	mixture	NN	I-NP
with	with	IN	0
given	given	VBN	0
radioligand	radioligand	JJ	B-NP
concentration	concentration	NN	I-NP
in	in	IN	0
untreated	untreated	NN	0
or	or	CC	0
treated	treated	JJ	0
media	media	NNS	0
were	were	VBD	0
incubated	incubated	VBN	0
at	at	IN	0
4°C	4°C	CD	0
for	for	IN	0
90	90	CD	0
min	min	NN	B-NP
,	,	,	0
unless	unless	IN	0
indicated	indicated	JJ	0
.	.	.	0
The	The	DT	0
free	free	JJ	0
and	and	CC	0
bound	bound	VBN	0
125I-PEDF	125I-PEDF	NNP	0
were	were	VBD	0
separated	separated	VBN	0
by	by	IN	0
filtration	filtration	NN	0
through	through	IN	0
glass-fiber	glass-fiber	JJ	B-NP
filter	filter	NN	I-NP
and	and	CC	0
the	the	DT	0
bound	bound	JJ	0
radioactivity	radioactivity	NN	0
was	was	VBD	0
determined	determined	VBN	0
in	in	IN	0
the	the	DT	0
filters	filters	NNS	0
using	using	VBG	0
a	a	DT	0
β-scintillation	β-scintillation	JJ	B-NP
counter	counter	NN	I-NP
(	(	-LRB-	0
Beckman	Beckman	NNP	0
,	,	,	0
model	model	NN	B-NP
l	l	NN	I-NP
3801	3801	CD	0
)	)	-RRB-	0
.	.	.	0
Nonspecific	Nonspecific	JJ	B-NP
binding	binding	NN	I-NP
was	was	VBD	0
calculated	calculated	VBN	0
from	from	IN	0
reactions	reactions	NNS	0
with	with	IN	0
a	a	DT	0
molar-excess	molar-excess	JJ	B-NP
of	of	IN	0
unlabeled	unlabeled	JJ	0
ligand	ligand	NN	B-NP
(	(	-LRB-	0
≥	≥	NNP	0
50-fold	50-fold	NNP	0
)	)	-RRB-	0
over	over	IN	0
radioligand	radioligand	NN	B-NP
.	.	.	0
complex	complex	JJ	B-NP
formation	formation	NN	I-NP
complex-formation	complex-formation	NN	I-NP
assay	assay	NN	I-NP
between	between	IN	0
pigment	pigment	NN	B-NP
epithelium	epithelium	NN	I-NP
derived	derived	VBN	I-NP
factor	factor	NN	I-NP
and	and	CC	0
CM	CM	NNP	0
components	components	NNS	0
was	was	VBD	0
assayed	assayed	VBN	0
by	by	IN	0
a	a	DT	0
method	method	NN	0
using	using	VBG	0
ultrafiltration	ultrafiltration	NN	B-NP
through	through	IN	0
membranes	membranes	NN	0
of	of	IN	0
100,000	100,000	CD	0
MW	MW	JJ	B-NP
exclusion	exclusion	NN	I-NP
limit	limit	NN	I-NP
[	[	-LRB-	0
14	14	CD	0
]	]	-RRB-	0
.	.	.	0
binding	binding	JJ	B-NP
reaction	reaction	NN	I-NP
were	were	VBD	0
performed	performed	VBN	0
with	with	IN	0
a	a	DT	0
given	given	VBN	0
concentration	concentration	NN	B-NP
of	of	IN	0
125I-PEDF	125I-PEDF	CD	0
in	in	IN	0
defined	defined	VBN	0
or	or	CC	0
conditioned	conditioned	JJ	0
media	media	NNS	0
,	,	,	0
and	and	CC	0
incubations	incubations	NN	0
with	with	IN	0
gentle	gentle	JJ	0
rotation	rotation	NN	B-NP
at	at	IN	0
4°C	4°C	CD	0
for	for	IN	0
2	2	CD	0
h	h	NNS	0
.	.	.	0
Free	Free	JJ	0
and	and	CC	0
bound	bound	JJ	0
ligand	ligand	NN	B-NP
were	were	VBD	0
separated	separated	VBN	0
by	by	IN	0
ultrafiltration	ultrafiltration	NN	B-NP
through	through	IN	0
Microcon-100	Microcon-100	NNP	B-NP
(	(	-LRB-	0
Amicon	Amicon	NNP	B-NP
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
reaction	reaction	NN	B-NP
mixture	mixture	NN	I-NP
were	were	VBD	0
diluted	diluted	VBN	0
40-fold	40-fold	CD	0
with	with	IN	0
cold	cold	JJ	0
20	20	CD	0
mM	mM	JJ	B-NP
sodium	sodium	NN	I-NP
phosphate	phosphate	VBP	I-NP
pH	pH	JJ	0
6.5	6.5	CD	0
,	,	,	0
20	20	CD	0
mM	mM	JJ	B-NP
NaCl	NaCl	NN	I-NP
,	,	,	0
10	10	CD	0
%	%	NN	0
glycerol	glycerol	NN	B-NP
and	and	CC	0
immediately	immediately	RB	0
ultrafiltrated	ultrafiltrated	JJ	0
,	,	,	0
repeating	repeating	VBG	0
twice	twice	RB	0
to	to	TO	0
ensure	ensure	VB	0
removal	removal	NN	0
of	of	IN	0
free	free	JJ	0
ligand	ligand	NN	B-NP
from	from	IN	0
the	the	DT	0
complexes	complexes	NNS	0
.	.	.	0
Each	Each	DT	0
Microcon	Microcon	JJ	B-NP
retenate	retenate	JJ	I-NP
cup	cup	NN	I-NP
was	was	VBD	0
transferred	transferred	VBN	0
to	to	TO	0
scintillation	scintillation	VB	B-NP
vial	vial	NN	I-NP
,	,	,	0
mixed	mixed	VBN	0
with	with	IN	0
5	5	CD	0
ml	ml	CD	0
BioSafe	BioSafe	JJ	0
II	II	NNP	0
liquid	liquid	JJ	B-NP
scintillation	scintillation	JJ	I-NP
solution	solution	NN	I-NP
(	(	-LRB-	0
research	research	NN	B-NP
product	product	NN	I-NP
International	International	NNP	0
)	)	-RRB-	0
by	by	IN	0
extensive	extensive	JJ	B-NP
vortexing	vortexing	NN	I-NP
,	,	,	0
and	and	CC	0
its	its	PRP$	0
radioactivity	radioactivity	NN	0
determined	determined	VBN	0
using	using	VBG	0
a	a	DT	0
β-scintillation	β-scintillation	JJ	B-NP
counter	counter	NN	I-NP
.	.	.	0
Nonspecific	Nonspecific	JJ	B-NP
binding	binding	NN	I-NP
,	,	,	0
calculated	calculated	VBN	0
from	from	IN	0
reactions	reactions	NNS	0
with	with	IN	0
an	an	DT	0
excess	excess	NN	0
of	of	IN	0
unlabeled	unlabeled	JJ	0
ligand	ligand	NN	B-NP
(	(	-LRB-	0
100-fold	100-fold	NNP	0
)	)	-RRB-	0
over	over	IN	0
radioligand	radioligand	NN	B-NP
,	,	,	0
reached	reached	VBN	0
about	about	IN	0
40	40	CD	0
%	%	NN	0
of	of	IN	0
the	the	DT	0
total	total	JJ	B-NP
binding	binding	NN	I-NP
.	.	.	0
enzymatic	enzymatic	NN	B-NP
digestion	digestion	JJ	I-NP
treatment	treatment	NN	I-NP
The	The	DT	0
presence	presence	NN	0
of	of	IN	0
GAGs	GAGs	NNP	0
was	was	VBD	0
assayed	assayed	VBN	0
using	using	VBG	0
specific	specific	JJ	0
gag	gag	NN	B-NP
lyas	lyas	NNP	I-NP
,	,	,	0
i.e.	i.e.	FW	0
,	,	,	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
heparin	heparin	NN	B-NP
,	,	,	0
heparan	heparan	NN	B-NP
sulfate	sulfate	NN	I-NP
,	,	,	0
and	and	CC	0
chondroitin	chondroitin	JJ	B-NP
sulfate	sulfate	NN	I-NP
with	with	IN	0
heparinase	heparinase	NN	B-NP
,	,	,	0
heparitinase	heparitinase	NN	B-NP
,	,	,	0
and	and	CC	0
chondroitin	chondroitin	JJ	B-NP
ABC	ABC	NNP	I-NP
respectively	respectively	RB	0
.	.	.	0
The	The	DT	0
amount	amount	NN	0
of	of	IN	0
GAGs	GAGs	NNP	0
was	was	VBD	0
determined	determined	VBN	0
by	by	IN	0
the	the	DT	0
amount	amount	NN	0
of	of	IN	0
Δ	Δ	NNP	0
4-hexuronate	4-hexuronate	NNP	0
produced	produced	VBD	0
after	after	IN	0
the	the	DT	0
eliminative	eliminative	JJ	B-NP
cleavage	cleavage	NN	I-NP
of	of	IN	0
each	each	DT	0
substrate	substrate	NN	0
by	by	IN	0
the	the	DT	0
corresponding	corresponding	JJ	0
GAG	GAG	NNP	B-NP
lyase	lyase	NN	I-NP
.	.	.	0
Samples	Samples	NNS	0
were	were	VBD	0
depleted	depleted	VBN	0
of	of	IN	0
proteins	proteins	NNS	0
by	by	IN	0
protease	protease	JJ	B-NP
treatment	treatment	NN	I-NP
to	to	TO	0
avoid	avoid	VB	0
interference	interference	NN	B-NP
in	in	IN	0
absorbance	absorbance	JJ	B-NP
reading	reading	NN	I-NP
of	of	IN	0
the	the	DT	0
product	product	NN	0
.	.	.	0
For	For	IN	0
heparinase	heparinase	NN	B-NP
and	and	CC	0
heparitinase	heparitinase	JJ	B-NP
reaction	reaction	NN	I-NP
,	,	,	0
samples	samples	NNS	0
were	were	VBD	0
treated	treated	VBN	0
with	with	IN	0
5	5	CD	0
milliunit	milliunit	NN	B-NP
of	of	IN	0
each	each	DT	0
enzyme	enzyme	NN	B-NP
in	in	IN	0
150	150	CD	0
μl	μl	NN	B-NP
of	of	IN	0
0.1	0.1	CD	0
M	M	NNP	0
sodium	sodium	NN	B-NP
acetate	acetate	NN	I-NP
and	and	CC	0
1	1	CD	0
mM	mM	JJ	0
CaCl	CaCl	JJ	B-NP
2	2	CD	0
,	,	,	0
pH	pH	JJ	0
7	7	CD	0
and	and	CC	0
incubations	incubations	NN	0
at	at	IN	0
37°C	37°C	CD	0
for	for	IN	0
various	various	JJ	0
time	time	NN	B-NP
period	period	NN	I-NP
.	.	.	0
The	The	DT	0
reactions	reactions	NNS	0
were	were	VBD	0
stopped	stopped	VBN	0
by	by	IN	0
the	the	DT	0
addition	addition	NN	B-NP
of	of	IN	0
1	1	CD	0
ml	ml	NN	0
of	of	IN	0
0.06	0.06	NNP	0
M	M	NNP	0
HCl	HCl	NNP	B-NP
.	.	.	0
The	The	DT	0
soluble	soluble	JJ	0
material	material	NN	0
was	was	VBD	0
separated	separated	VBN	0
by	by	IN	0
centrifugation	centrifugation	NN	B-NP
(	(	-LRB-	0
3000	3000	CD	0
×	×	CD	0
g	g	NN	0
,	,	,	0
10	10	CD	0
min	min	CD	B-NP
)	)	-RRB-	0
and	and	CC	0
assayed	assayed	NN	0
for	for	IN	0
absorbance	absorbance	NN	B-NP
at	at	IN	0
235	235	CD	0
nm	nm	NN	B-NP
to	to	TO	0
measure	measure	VB	0
the	the	DT	0
concentration	concentration	NN	B-NP
of	of	IN	0
product	product	NN	0
Δ	Δ	NNP	0
4-hexuronate	4-hexuronate	NNP	0
(	(	-LRB-	0
Molar	Molar	FW	0
extinction	extinction	FW	0
coefficient	coefficient	FW	0
=	=	SYM	0
5500	5500	CD	0
;	;	:	0
[	[	-LRB-	0
33	33	CD	0
]	]	CD	0
)	)	-RRB-	0
.	.	.	0
For	For	IN	0
the	the	DT	0
chondroitinase	chondroitinase	JJ	B-NP
abc	abc	NN	I-NP
reaction	reaction	NN	I-NP
,	,	,	0
each	each	DT	0
chondroitin	chondroitin	JJ	B-NP
sulfate	sulfate	NN	I-NP
A	A	NN	0
,	,	,	0
B	B	NNP	0
and	and	CC	0
C	C	$	0
substrate	substrate	CD	0
(	(	-LRB-	0
1	1	CD	0
mg	mg	CD	B-NP
each	each	CD	0
)	)	-RRB-	0
and	and	CC	0
concentrated	concentrated	JJ	0
CM	CM	NNP	0
,	,	,	0
were	were	VBD	0
incubated	incubated	VBN	0
with	with	IN	0
0.12	0.12	CD	0
units	units	NNS	0
of	of	IN	0
chondroitinase	chondroitinase	JJ	B-NP
ABC	ABC	NNP	I-NP
in	in	IN	0
1	1	CD	0
ml	ml	NN	0
of	of	IN	0
50	50	CD	0
mM	mM	JJ	B-NP
Tris-HCl	Tris-HCl	JJ	I-NP
pH	pH	JJ	0
8.0	8.0	NN	0
,	,	,	0
60	60	CD	0
mM	mM	JJ	B-NP
sodium	sodium	JJ	I-NP
acetate	acetate	NN	I-NP
,	,	,	0
and	and	CC	0
0.02	0.02	CD	0
%	%	NN	0
BSA	BSA	NN	B-NP
at	at	IN	0
37°C	37°C	CD	0
.	.	.	0
At	At	IN	0
various	various	JJ	0
time	time	NN	B-NP
period	period	NN	I-NP
,	,	,	0
aliquots	aliquots	VBG	0
of	of	IN	0
0.1	0.1	CD	0
ml	ml	NNS	0
were	were	VBD	0
removed	removed	VBN	0
and	and	CC	0
mixed	mixed	VBN	0
with	with	IN	0
0.9	0.9	CD	0
ml	ml	NN	0
of	of	IN	0
45	45	CD	0
mM	mM	JJ	0
KCl	KCl	JJ	B-NP
pH	pH	JJ	0
1.8	1.8	CD	0
to	to	TO	0
stop	stop	VB	0
the	the	DT	0
reaction	reaction	NN	0
.	.	.	0
Insoluble	Insoluble	JJ	0
material	material	NN	0
was	was	VBD	0
removed	removed	VBN	0
by	by	IN	0
centrifugation	centrifugation	NN	B-NP
(	(	-LRB-	0
1000	1000	CD	0
×	×	CD	0
g	g	NN	0
,	,	,	0
10	10	CD	0
min	min	CD	B-NP
)	)	-RRB-	0
and	and	CC	0
the	the	DT	0
absorbance	absorbance	NN	B-NP
supernatant	supernatant	JJ	I-NP
assayed	assayed	NN	I-NP
of	of	IN	0
Δ	Δ	NNP	0
4-hexuronate	4-hexuronate	NNP	0
at	at	IN	0
232	232	CD	0
nm	nm	NN	B-NP
.	.	.	0
For	For	IN	0
protein	protein	NN	B-NP
depletion	depletion	NN	I-NP
,	,	,	0
CM	CM	NNP	0
was	was	VBD	0
mixed	mixed	VBN	0
with	with	IN	0
subtilisin	subtilisin	NN	B-NP
at	at	IN	0
0.4	0.4	CD	0
μg	μg	CD	B-NP
/	/	CD	I-NP
ml	ml	NN	I-NP
in	in	IN	0
20	20	CD	0
mM	mM	JJ	B-NP
Tris-HCl	Tris-HCl	JJ	I-NP
pH	pH	JJ	0
8.0	8.0	NN	0
,	,	,	0
10	10	CD	0
%	%	NN	0
glycerol	glycerol	NN	B-NP
and	and	CC	0
incubated	incubated	NN	0
at	at	IN	0
37°C	37°C	CD	0
for	for	IN	0
16	16	CD	0
h	h	NN	B-NP
.	.	.	I-NP
Subtilisin	Subtilisin	NNP	I-NP
was	was	VBD	0
heat-inactivated	heat-inactivated	JJ	0
at	at	IN	0
75°C	75°C	CD	0
for	for	IN	0
25	25	CD	0
min	min	NN	B-NP
.	.	.	0
The	The	DT	0
protein	protein	NN	B-NP
concentration	concentration	NN	I-NP
after	after	IN	0
the	the	DT	0
reaction	reaction	NN	0
was	was	VBD	0
less	less	JJR	0
than	than	IN	0
0.1	0.1	CD	0
%	%	NN	0
of	of	IN	0
the	the	DT	0
starting	starting	VBG	B-NP
material	material	NN	I-NP
.	.	.	0
To	To	TO	0
deplete	deplete	VB	0
cell	cell	NN	0
cultures	cultures	NNS	0
of	of	IN	0
GAGs	GAGs	NNP	0
,	,	,	0
Y-79	Y-79	CD	0
cells	cells	NNS	0
in	in	IN	0
defined	defined	VBN	0
serum-free	serum-free	JJ	0
medium	medium	NN	0
(	(	-LRB-	0
as	as	IN	0
above	above	JJ	0
)	)	-RRB-	0
at	at	IN	0
a	a	DT	0
density	density	NN	0
of	of	IN	0
1.25	1.25	CD	0
×	×	CD	0
10	10	CD	0
5cells	5cells	CD	0
/	/	CD	0
ml	ml	NNS	0
were	were	VBD	0
cultured	cultured	VBN	0
in	in	IN	0
96-well	96-well	CD	0
culture	culture	NN	0
plates	plates	NNS	0
(	(	-LRB-	0
150	150	CD	0
μl	μl	NNS	0
/	/	VBP	0
well	well	RB	0
)	)	-RRB-	0
and	and	CC	0
incubated	incubated	NN	0
at	at	IN	0
37°C	37°C	CD	0
in	in	IN	0
a	a	DT	0
5	5	CD	0
%	%	NN	0
CO	CO	NNP	0
2	2	CD	0
environment	environment	NN	0
for	for	IN	0
16	16	CD	0
h	h	NNS	0
.	.	.	0
Hyaluronidase	Hyaluronidase	NNP	0
(	(	-LRB-	0
>	>	FW	0
1TRU	1TRU	FW	0
/	/	FW	0
μl	μl	FW	0
)	)	-RRB-	0
,	,	,	0
heparinase	heparinase	NNS	0
(	(	-LRB-	0
1	1	CD	0
mu	mu	CD	0
/	/	CD	0
μl	μl	CD	0
)	)	-RRB-	0
or	or	CC	0
heparitinase	heparitinase	NNS	0
(	(	-LRB-	0
1	1	CD	0
mu	mu	CD	0
/	/	CD	0
μl	μl	CD	0
)	)	-RRB-	0
were	were	VBD	0
each	each	DT	0
added	added	VBN	0
to	to	TO	0
various	various	JJ	0
wells	wells	NNS	0
and	and	CC	0
incubated	incubated	NN	0
at	at	IN	0
37°C	37°C	CD	0
in	in	IN	0
a	a	DT	0
5	5	CD	0
%	%	NN	0
CO	CO	NNP	0
2	2	CD	0
environment	environment	NN	0
for	for	IN	0
1	1	CD	0
h	h	NNS	0
.	.	.	0
Chlorate	Chlorate	JJ	0
treatment	treatment	NN	0
of	of	IN	0
cell	cell	NN	0
cultures	cultures	NNS	0
To	To	TO	0
prevent	prevent	VB	0
sulfation	sulfation	VBN	0
of	of	IN	0
GAGs	GAGs	JJ	0
in	in	IN	0
cell	cell	NN	0
cultures	cultures	NNS	0
,	,	,	0
we	we	PRP	0
used	used	VBD	0
a	a	DT	0
method	method	NN	0
previously	previously	RB	0
described	described	VBN	0
[	[	-LRB-	0
33	33	CD	0
]	]	-RRB-	0
.	.	.	0
Y-79	Y-79	NNP	0
cells	cells	NNS	0
(	(	-LRB-	0
1.25	1.25	CD	0
×	×	CD	0
10	10	CD	0
5cells	5cells	CD	0
/	/	CD	0
ml	ml	CD	0
)	)	-RRB-	0
were	were	VBD	0
cultured	cultured	VBN	0
in	in	IN	0
48-well	48-well	CD	0
plates	plates	NNS	0
(	(	-LRB-	0
300	300	CD	0
μl	μl	NNS	0
/	/	VBP	0
well	well	RB	0
)	)	-RRB-	0
in	in	IN	0
defined	defined	VBN	0
serum-free	serum-free	JJ	0
medium	medium	NN	0
with	with	IN	0
or	or	CC	0
without	without	IN	0
30	30	CD	0
mM	mM	JJ	0
sodium	sodium	NN	0
chlorate	chlorate	NNS	0
and	and	CC	0
10	10	CD	0
mM	mM	JJ	0
sodium	sodium	JJ	0
sulfate	sulfate	NN	0
at	at	IN	0
37°C	37°C	CD	0
in	in	IN	0
a	a	DT	0
5	5	CD	0
%	%	NN	0
CO	CO	NNP	0
2	2	CD	0
environment	environment	NN	0
for	for	IN	0
24	24	CD	0
h	h	NNS	0
.	.	.	0
GAG	GAG	NNP	0
detection	detection	FW	0
assays	assays	FW	0
GAGs	GAGs	FW	0
and	and	CC	0
proteins	proteins	NNS	0
resolved	resolved	VBN	0
by	by	IN	0
sds-polyacrylamide	sds-polyacrylamide	NN	B-NP
gel	gel	JJ	I-NP
electrophoresi	electrophoresi	NN	I-NP
in	in	IN	0
Tricine	Tricine	NNP	B-NP
/	/	NNP	I-NP
SDS	SDS	NNP	I-NP
buffer	buffer	NN	I-NP
,	,	,	0
as	as	RB	0
instructed	instructed	VBN	0
by	by	IN	0
manufacturer	manufacturer	NN	B-NP
(	(	-LRB-	0
Novex	Novex	NNP	B-NP
)	)	-RRB-	0
,	,	,	0
were	were	VBD	0
detected	detected	VBN	0
with	with	IN	0
specific	specific	JJ	0
stains	stains	NNS	0
.	.	.	0
For	For	IN	0
GAG	GAG	NNP	0
detection	detection	NN	0
,	,	,	0
the	the	DT	0
gels	gels	NN	0
were	were	VBD	0
incubated	incubated	JJ	0
sequentially	sequentially	NN	0
in	in	IN	0
0.2	0.2	CD	0
%	%	NN	0
Toluidine	Toluidine	NNP	B-NP
Blue-O	Blue-O	NNP	I-NP
in	in	IN	0
ethanol-water-acetic	ethanol-water-acetic	JJ	B-NP
acid	acid	NN	I-NP
(	(	-LRB-	0
50	50	CD	0
:	:	:	0
49	49	CD	0
:	:	:	0
1	1	LS	0
)	)	-RRB-	0
for	for	IN	0
30	30	CD	0
minutes	minutes	NNS	0
,	,	,	0
in	in	IN	0
ethanol-water-acetic	ethanol-water-acetic	JJ	B-NP
acid	acid	NN	I-NP
(	(	-LRB-	0
50	50	CD	0
:	:	:	0
49	49	CD	0
:	:	:	0
1	1	LS	0
)	)	-RRB-	0
for	for	IN	0
1	1	CD	0
h	h	NN	0
,	,	,	0
and	and	CC	0
in	in	IN	0
H	H	NNP	0
2	2	CD	0
O	O	NN	0
for	for	IN	0
16	16	CD	0
h.	h.	CD	0
[	[	-LRB-	0
34	34	CD	0
]	]	-RRB-	0
.	.	.	0
For	For	IN	0
protein	protein	NN	B-NP
detection	detection	NN	I-NP
,	,	,	0
the	the	DT	0
gels	gels	NN	0
were	were	VBD	0
sequentially	sequentially	JJ	0
incubated	incubated	NN	0
in	in	IN	0
0.5	0.5	CD	0
%	%	NN	0
Coomassie	Coomassie	NNP	B-NP
Brilliant	Brilliant	NNP	I-NP
Blue	Blue	NNP	I-NP
in	in	IN	0
50	50	CD	0
%	%	NN	0
methanol	methanol	VBD	0
/	/	CD	0
10	10	CD	0
%	%	NN	0
acetic	acetic	NN	B-NP
acid	acid	NN	I-NP
and	and	CC	0
in	in	IN	0
10	10	CD	0
%	%	NN	0
methanol	methanol	VBD	0
/	/	CD	0
10	10	CD	0
%	%	NN	0
isopropanol	isopropanol	NN	B-NP
.	.	.	0
GAG	GAG	NNP	0
detection	detection	NN	0
was	was	VBD	0
also	also	RB	0
performed	performed	VBN	0
by	by	IN	0
the	the	DT	0
Toluidine	Toluidine	JJ	B-NP
Blue-O	Blue-O	JJ	I-NP
precipitation	precipitation	NN	I-NP
and	and	CC	0
dot-blot	dot-blot	JJ	B-NP
method	method	NN	I-NP
as	as	IN	0
described	described	VBN	0
previously	previously	RB	0
[	[	-LRB-	0
34	34	CD	0
]	]	-RRB-	0
.	.	.	0
Briefly	Briefly	RB	0
,	,	,	0
200	200	CD	0
μl	μl	NN	B-NP
of	of	IN	0
sample	sample	NN	0
were	were	VBD	0
applied	applied	VBN	0
to	to	TO	0
each	each	DT	0
well	well	RB	0
of	of	IN	0
a	a	DT	0
48-well	48-well	CD	0
manifold	manifold	NNS	0
(	(	-LRB-	0
Life	Life	NNP	0
Technologies	Technologies	NNPS	0
)	)	-RRB-	0
onto	onto	IN	0
a	a	DT	0
PVDF	PVDF	NNP	B-NP
membrane	membrane	NN	I-NP
without	without	IN	0
vacuum	vacuum	NN	B-NP
.	.	.	0
Then	Then	RB	0
,	,	,	0
5	5	CD	0
μl	μl	NN	B-NP
of	of	IN	0
0.2	0.2	CD	0
%	%	NN	0
Toluidine	Toluidine	NNP	B-NP
blue-O	blue-O	NNP	I-NP
were	were	VBD	0
added	added	VBN	0
to	to	TO	0
each	each	DT	0
well	well	RB	0
and	and	CC	0
vacuum	vacuum	NN	B-NP
was	was	VBD	0
applied	applied	VBN	0
.	.	.	0
The	The	DT	0
membrane	membrane	NN	0
was	was	VBD	0
removed	removed	VBN	0
,	,	,	0
washed	washed	VBD	0
twice	twice	RB	0
with	with	IN	0
destaining	destaining	JJ	B-NP
solution	solution	NN	I-NP
(	(	-LRB-	0
ethanol-water-acetic	ethanol-water-acetic	JJ	B-NP
acid	acid	NN	I-NP
,	,	,	0
50	50	CD	0
:	:	:	0
49	49	CD	0
:	:	:	0
1	1	LS	0
)	)	-RRB-	0
for	for	IN	0
5	5	CD	0
min	min	NN	B-NP
and	and	CC	0
air-dried	air-dried	JJ	0
.	.	.	0
Other	Other	JJ	0
methods	methods	NNS	0
The	The	DT	0
protein	protein	NN	0
concentration	concentration	NN	0
was	was	VBD	0
determined	determined	VBN	0
using	using	VBG	0
BioRad	BioRad	JJ	0
Protein	Protein	NNP	0
Assay	Assay	NNP	0
(	(	-LRB-	0
BioRad	BioRad	NNP	0
)	)	-RRB-	0
.	.	.	0
pigment	pigment	NN	B-NP
epithelium	epithelium	NN	I-NP
derived	derived	VBN	I-NP
factor	factor	NN	I-NP
abbreviation	abbreviation	NN	I-NP
,	,	,	0
pigment	pigment	JJ	B-NP
epithelium-derived	epithelium-derived	JJ	I-NP
factor	factor	NN	I-NP
;	;	:	0
GAG	GAG	NNP	0
,	,	,	0
glycosaminoglycan	glycosaminoglycan	NN	B-NP
;	;	:	0
heparan	heparan	NN	B-NP
sulfate	sulfate	NN	I-NP
,	,	,	0
heparan	heparan	JJ	B-NP
sulfate	sulfate	NN	I-NP
;	;	:	0
CM	CM	NNP	0
,	,	,	0
media	media	NNS	0
conditioned	conditioned	VBN	0
by	by	IN	0
retinoblastoma	retinoblastoma	NN	B-NP
cell	cell	NN	I-NP
.	.	.	0
Authors	Authors	NNP	0
'	'	POS	0
ema	ema	NNP	B-NP
contribution	contribution	NN	I-NP
participated	participated	VBD	0
in	in	IN	0
the	the	DT	0
design	design	NN	0
,	,	,	0
assay	assay	JJ	B-NP
development	development	NN	I-NP
and	and	CC	0
carried	carried	VBD	0
out	out	RP	0
the	the	DT	0
complex-formation	complex-formation	JJ	B-NP
,	,	,	0
GAG	GAG	NNP	0
detection	detection	NN	0
and	and	CC	0
receptor	receptor	JJ	B-NP
binding	binding	JJ	I-NP
assay	assay	NN	I-NP
.	.	.	0
JEW	JEW	NNP	B-NP
carried	carried	VBD	0
out	out	RP	0
the	the	DT	0
purification	purification	NN	B-NP
and	and	CC	0
characterization	characterization	NN	B-NP
of	of	IN	0
GAGs	GAGs	NNP	0
,	,	,	0
the	the	DT	0
enzymatic	enzymatic	NN	B-NP
and	and	CC	0
chemical	chemical	JJ	B-NP
treatment	treatment	NN	I-NP
of	of	IN	0
cell	cell	NN	0
cultures	cultures	NNS	0
for	for	IN	0
receptor	receptor	JJ	B-NP
binding	binding	JJ	I-NP
study	study	NN	I-NP
,	,	,	0
and	and	CC	0
drafted	drafted	VBD	0
the	the	DT	0
manuscript	manuscript	NN	0
.	.	.	0
SPB	SPB	NNP	B-NP
conceived	conceived	VBD	0
the	the	DT	0
study	study	NN	0
,	,	,	0
and	and	CC	0
participated	participated	VBD	0
in	in	IN	0
its	its	PRP$	0
design	design	NN	0
and	and	CC	0
coordination	coordination	NN	B-NP
.	.	.	0
All	All	DT	0
authors	authors	NNS	0
read	read	VBP	0
and	and	CC	0
approved	approved	VBD	0
the	the	DT	0
final	final	JJ	B-NP
manuscript	manuscript	NN	I-NP
.	.	.	0
